<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/250928</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Bioinformatics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>HIF-2&#x03B1; is essential for carotid body development and function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8676-1964</contrib-id>
<name><surname>Mac&#x00ED;as</surname> <given-names>David</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cowburn</surname> <given-names>Andrew S.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Torres-Torrelo</surname> <given-names>Hortensia</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ortega-S&#x00E1;enz</surname> <given-names>Patricia</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>L&#x00F3;pez-Barneo</surname> <given-names>Jos&#x00E9;</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4084-6639</contrib-id>
<name><surname>S. Johnson</surname> <given-names>Randall</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="corresp" rid="cor1">5</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Physiology, Development and Neuroscience, University of Cambridge</institution>, Cambridge, <country>UK</country></aff>
<aff id="a2"><label>2</label><institution>Department of Medicine, University of Cambridge</institution>, Cambridge, <country>UK</country></aff>
<aff id="a3"><label>3</label><institution>Instituto de Biomedicina de Sevilla (IBiS)</institution>, Seville, <country>Spain</country>.</aff>
<aff id="a4"><label>4</label><institution>Department of Cell and Molecular Biology</institution>, Karolinska Institute, Stockholm, <country>Sweden</country>.</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<label>5</label> For correspondence: Professor Randall S. Johnson, <institution>Department of Physiology, Development and Neuroscience, University of Cambridge</institution>, Downing Street, Cambridge. CB2 3EG. <country>United Kingdom</country>. E-mail: <email>rsj33@cam.ac.uk</email></corresp></author-notes>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>250928</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>1</month>
<year>2018</year>
</date>
</history><permissions><copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions>
<self-uri xlink:href="250928.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Summary</title>
<p>Mammalian adaptation to oxygen flux occurs at many levels, from shifts in cellular metabolism to physiological adaptations facilitated by the sympathetic nervous system and carotid body (CB). Interactions between differing forms of adaptive response to hypoxia, including transcriptional responses orchestrated by the Hypoxia Inducible transcription Factors (HIFs), are complex and clearly synergistic. We show here that there is an absolute developmental requirement for HIF-2a, one of the HIF isoforms, for growth and survival of oxygen sensitive glomus cells of the carotid body. The loss of these cells renders mice incapable of ventilatory responses to hypoxia, and this has striking effects on processes as diverse as arterial pressure regulation, exercise performance, and glucose homeostasis. We show that the expansion of the glomus cells is correlated with mTORC1 activation, and is functionally inhibited by rapamycin treatment. These findings demonstrate the central role played by HIF-2a in carotid body development, growth and function.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>hypoxia</kwd>
<kwd>carotid body</kwd>
<kwd>oxygen sensing</kwd>
<kwd>HIF-2&#x03B1;</kwd>
<kwd>HVR</kwd>
<kwd>physiological responses</kwd>
</kwd-group>
<counts>
<page-count count="71"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Detecting and responding to shifts in oxygen availability is essential for animal survival. Responding to changes in oxygenation occurs in cells, tissues, and at the level of the whole organism. Although many of responses to oxygen flux are regulated at the transcriptional level by the hypoxia inducible transcription factor (HIF), at tissue and organismal levels there are even more dimensions to the adaptive process. In vertebrates, the actors in adaptation are found in different peripheral chemoreceptors, including the neuroepithelial cells of the gills in teleosts, and in the carotid body (CB) of mammals. The CB regulates many responses to changes in oxygenation, including alterations in ventilation and heart rates.</p>
<p>The carotid body is located at the carotid artery bifurcation, and contains glomeruli that contain O<sub>2</sub>-sensitive, neuron-like tyrosine hydroxylase (TH)-positive glomus cells (type I cells). These glomus cells are responsible for a rapid compensatory hypoxic ventilatory response (HVR) when a drop in arterial O<sub>2</sub> tension (PO<sub>2</sub>) occurs (<xref rid="c31" ref-type="bibr">Lopez-Barneo, Ortega-Saenz, et al., 2016</xref>; <xref rid="c55" ref-type="bibr">Teppema &#x0026; Dahan, 2010)</xref>. In addition to this acute reflex, the CB plays an important role in acclimatization to sustained hypoxia, and is commonly enlarged in people living at high altitude (<xref rid="c2" ref-type="bibr">Arias-Stella &#x0026; Valcarcel, 1976</xref>; <xref rid="c58" ref-type="bibr">Wang &#x0026; Bisgard, 2002</xref>) and in patients with chronic respiratory diseases (<xref rid="c16" ref-type="bibr">Heath &#x0026; Edwards, 1971</xref>; <xref rid="c17" ref-type="bibr">Heath, Smith, &#x0026; Jago, 1982</xref>). This enlargement is induced through a proliferative response of CB stem cells (type II cells)(<xref rid="c40" ref-type="bibr">Pardal, Ortega-Saenz, Duran, &#x0026; Lopez-Barneo, 2007</xref>; <xref rid="c46" ref-type="bibr">Platero-Luengo et al., 2014</xref>).</p>
<p>During embryogenesis, the initiating event in CB organogenesis occurs when multipotent neural crest cells migrate toward the dorsal aorta, to give rise to the sympathoadrenal system (<xref rid="c28" ref-type="bibr">Le Douarin, 1986</xref>). Segregation of sympathetic progenitors from the superior cervical ganglion (SCG) then creates the CB parenchyma (<xref rid="c22" ref-type="bibr">Kameda, 2005</xref>; <xref rid="c23" ref-type="bibr">Kameda, Ito, Nishimaki, &#x0026; Gotoh, 2008</xref>). This structure is comprised of O<sub>2</sub>-sensitive glomus cells (type-I cells) (<xref rid="c41" ref-type="bibr">Pearse et al., 1973)</xref>, glia-like sustentacular cells (type-II cells) (<xref rid="c40" ref-type="bibr">Pardal et al., 2007</xref>) and endothelial cells (<xref rid="c1" ref-type="bibr">Annese, Navarro-Guerrero, Rodriguez-Prieto, &#x0026; Pardal, 2017</xref>).</p>
<p>The cellular response to low oxygen is in part modulated by two isoforms of the HIF-&#x03B1; transcription factor, each with differing roles in cellular and organismal response to oxygen flux: HIF-1&#x03B1; and HIF-2&#x03B1;. At the organismal level, mouse models hemizygous for HIFs-&#x03B1; (<italic>Hif-1&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup> and <italic>Hif-2&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup>) or where HIF inactivation was induced in adults showed contrasting effects on CB function, without in either case affecting CB morphogenesis (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>; <xref rid="c25" ref-type="bibr">Kline, Peng, Manalo, Semenza, &#x0026; Prabhakar, 2002</xref>; <xref rid="c43" ref-type="bibr">Y. J. Peng et al., 2011</xref>).</p>
<p>Transcriptome analysis has confirmed that <italic>Hif-2&#x03B1;</italic> is the second most abundant transcript in neonatal CB glomus cells (<xref rid="c57" ref-type="bibr">Tian, Hammer, Matsumoto, Russell, &#x0026; McKnight, 1998</xref>; <xref rid="c59" ref-type="bibr">Zhou, Chien, Kaleem, &#x0026; Matsunami, 2016</xref>), and that it is expressed at far higher levels than are found in cells of similar developmental origins, including superior cervical ganglion (SCG) sympathetic neurons (<xref rid="c13" ref-type="bibr">Gao et al., 2017</xref>). It has also been recently shown that <italic>Hif-2&#x03B1;</italic>, but not <italic>Hif-1&#x03B1;</italic>, overexpression in sympathoadrenal cells leads to enlargement of the CB (<xref rid="c35" ref-type="bibr">Macias, Fernandez-Aguera, Bonilla-Henao, &#x0026; Lopez-Barneo, 2014</xref>). Here, we report that HIF-2&#x03B1; is required for the development of CB O<sub>2</sub>-sensitive glomus cells, and that mutant animals lacking CB function have impaired adaptive physiological responses.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Sympathoadrenal <italic>Hif-2&#x03B1;</italic> loss blocks carotid body glomus cell development</title>
<p>To elucidate the role of HIF&#x03B1; isoforms in CB development and function, we generated mouse strains carrying <italic>Hif-1&#x03B1;</italic> or <italic>Hif-2&#x03B1;</italic> embryonic deletions (TH-HIF-1&#x03B1;<sup>KO</sup> and TH-HIF-2&#x03B1;<sup>KO</sup>) restricted to catecholaminergic tissues by crossing them with a mouse strain expressing cre recombinase under the control of the endogenous tyrosine hydroxylase (TH) promoter (<xref rid="c35" ref-type="bibr">Macias et al., 2014)</xref>.</p>
<p>Histological analysis of the carotid artery bifurcation dissected from adult TH-HIF-2&#x03B1;<sup>KO</sup> mice revealed virtually no CB TH<sup>&#x002B;</sup> glomus cells (<xref rid="fig1" ref-type="fig">Figure 1A</xref>, bottom panels) compared to HIF-2&#x03B1;<sup>WT</sup> littermate controls (<xref rid="fig1" ref-type="fig">Figure 1A</xref>, top panels). Conversely, TH-HIF-1&#x03B1;<sup>KO</sup> mice showed a typical glomus cell organization, characterized by scattered clusters of TH<sup>&#x002B;</sup> cells throughout the CB parenchyma (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, bottom panels) similar to those found in HIF-1&#x03B1;<sup>WT</sup> littermate controls (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, top panels). These observations were further corroborated by quantification of the total CB parenchyma volume (<xref rid="fig1" ref-type="fig">Figure 1D-1F</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption>
<p>Selective loss of carotid body glomus cells in sympathoadrenal-specific <italic>Hif-2&#x03B1;</italic>, but not <italic>Hif-1&#x03B1;</italic>, deficient mice. (A and B) Tyrosine hydroxylase (TH) immunostaining on carotid bifurcation sections from HIF-2&#x03B1;<sup>WT</sup> (A, top panels), TH-HIF-2&#x03B1;<sup>KO</sup> (A, bottom panels), HIF-1&#x03B1;<sup>WT</sup> (B, top panels) and TH-HIF-1&#x03B1;<sup>KO</sup> (B, bottom panels) mice. Micrographs showed in A (bottom) were selected to illustrate the rare presence of TH<sup>&#x002B;</sup> glomus cells in TH-HIF-2&#x03B1;<sup>KO</sup> mice (white arrowheads). Dashed rectangles (left panels) are shown at higher magnification on the right panels. SCG, superior cervical ganglion; CB, carotid body; ICA, internal carotid artery; ECA, external carotid artery. Scale bars: 200 &#x03BC;m (left panels), 50 &#x03BC;m (right panels). (C-F) Quantification of total SCG volume (C), total CB volume (D), TH<sup>&#x002B;</sup> cell number (E) and TH<sup>&#x002B;</sup> cell density (F) on micrograph from HIF-2&#x03B1;<sup>WT</sup> (black dots, n = 4 for SCG and n = 6 for CB), TH-HIF-2&#x03B1;<sup>KO</sup> (red squares, n = 4), HIF-1&#x03B1;<sup>WT</sup> (black triangles, n = 4) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue triangles, n = 3) mice. Data are expressed as mean &#x00B1; SEM. Mann-Whitney test, &#x002A;&#x002A;p &#x003C; 0.001; ns, non-significant. (G and H) TH-immunostained adrenal gland sections from HIF-2&#x03B1;<sup>WT</sup> (G, top panel), TH-HIF-2&#x03B1;<sup>KO</sup> (G, bottom panel), HIF-1&#x03B1;<sup>WT</sup> (H, top panel) and TH-HIF-1&#x03B1;<sup>KO</sup> (H, bottom panel) littermates. AM, adrenal medulla. Scale bars: 200 &#x03BC;m. (I) Normalized adrenaline (left) and noradrenaline (right) urine content measured by ELISA. HIF-2&#x03B1;<sup>WT</sup> (black dots, n = 8), TH-HIF-2&#x03B1;<sup>KO</sup> (red squares, n = 7), HIF-1&#x03B1;<sup>WT</sup> (black triangles, n = 7) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue triangles, n = 4). Mann-Whitney test, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_fig1.tif"/>
</fig>
<p>Other catecholaminergic organs whose embryological origins are similar to those of the CB, e.g., the superior cervical ganglion (SCG), do not show significant differences in structure or volume between TH-HIF-2&#x03B1;<sup>KO</sup> mutants and control mice (<xref rid="fig1" ref-type="fig">Figure 1A-C</xref>). This suggests a specific role of HIF-2&#x03B1; in the development of the CB glomus cells, and argues against a global role for the gene in development of catecholaminergic tissues. Further evidence for this comes from phenotypic characterization of adrenal medulla (AM) TH<sup>&#x002B;</sup> chromaffin cells. No major histological alterations were observed in adrenal glands removed from TH-HIF-2&#x03B1;<sup>KO</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> mutant mice compared to HIF-2&#x03B1;<sup>WT</sup> and HIF-1&#x03B1;<sup>WT</sup> littermate controls (<xref rid="fig1" ref-type="fig">Figure 1G and H</xref>). Consistent with this, the amount of catecholamine (adrenaline and noradrenaline) present in the urine of TH-HIF-2&#x03B1;<sup>KO</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> deficient mice was similar to that found in their respective littermate controls (<xref rid="fig1" ref-type="fig">Figure 1I</xref>).</p>
<p>To determine deletion frequencies in these tissues, we crossed a loxP-flanked Td-Tomato reporter strain (<xref rid="c37" ref-type="bibr">Madisen et al., 2010</xref>) with TH-IRES-Cre mouse mice. Td-Tomato<sup>&#x002B;</sup> signal was only detected within the CB, SCG and AM of mice expressing cre recombinase under the control of the <italic>Th</italic> promoter (<xref rid="figS1a" ref-type="fig">Figure 1-figure supplement 1A</xref>). Additionally, SCG and AM from HIF-2&#x03B1;<sup>WT</sup>, HIF-1&#x03B1;<sup>WT</sup>, TH-HIF-2&#x03B1;<sup>KO</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> were quantified for <italic>Hif-2&#x03B1;</italic> and <italic>Hif-1&#x03B1;</italic> deletion efficiency using genomic DNA. As expected, there is a significant level of deletion of <italic>Hif-2&#x03B1;</italic> and <italic>Hif-1&#x03B1;</italic> genes detected in TH-HIF-2&#x03B1;<sup>KO</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> mutant mice compared to HIF-2&#x03B1;<sup>WT</sup> and HIF-1&#x03B1;<sup>WT</sup> littermates controls (<xref rid="figS1a" ref-type="fig">Figure 1-figure supplement 1B and C</xref>).</p>
<p>To determine whether absence of CB glomus cells in adult TH-HIF-2&#x03B1;<sup>KO</sup> mice is a result of impaired glomus cell differentiation or cell survival, we examined carotid artery bifurcations dissected from TH-HIF-2&#x03B1;<sup>KO</sup> mice at embryonic stage E18.5 (i.e., 1-2 days before birth), and postnatally (P0) (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). Differentiated TH<sup>&#x002B;</sup> glomus cells were found in the carotid bifurcation of TH-and K<sup>&#x002B;</sup> HIF-2&#x03B1;<sup>KO</sup> mutant mice at both stages (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). However, there is a significant reduction in the total CB parenchyma volume and in the number of differentiated TH<sup>&#x002B;</sup> glomus cells in TH-HIF-2&#x03B1;<sup>KO</sup> mice at E18.5, and this reduction is even more evident in newborn mice (<xref rid="fig2" ref-type="fig">Figure 2B and C</xref>). Since CB volume and cells number of mutant mice decreased in parallel, no significant changes were seen in TH<sup>&#x002B;</sup> cell density at these two time points, however (<xref rid="fig2" ref-type="fig">Figure 2D</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption>
<p>Progressive CB glomus cells death during development of TH-HIF2&#x03B1;<sup>KO</sup> mouse. (A) Representative micrographs illustrating CB TH<sup>&#x002B;</sup> glomus cells appearance at embryo stage E18.5 (left) and postnatal stage P0 (right) in HIF-2&#x03B1;<sup>WT</sup> (top panels) and TH-HIF-2&#x03B1;<sup>KO</sup> (bottom panels) mice. Dashed rectangles (left panels) are shown at higher magnification on the right panels. SCG, superior cervical ganglion; CB, carotid body; ICA, internal carotid artery; ECA, external carotid artery. Scale bars: 100 &#x03BC;m. (B-E) Quantitative histological analysis of CB volume (B), TH<sup>&#x002B;</sup> cells number (C), TH<sup>&#x002B;</sup> cell density (D) and SCG volume (E) from TH-HIF-2&#x03B1;<sup>KO</sup> compared to HIF-2&#x03B1;<sup>WT</sup> mice. HIF-2&#x03B1;<sup>WT</sup> (E18.5, n = 8; P0, n = 4; SCG, n = 5), TH-HIF-2&#x03B1;<sup>KO</sup> (E18.5, n = 7; P0, n= 5; SCG, n = 5). SCG, superior cervical ganglion. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non significant. (F) Representative pictures of double TH<sup>&#x002B;</sup> and TUNEL<sup>&#x002B;</sup> (white arrows) stained carotid bifurcation sections from HIF-2&#x03B1;<sup>WT</sup> (top panels) and TH-HIF-2&#x03B1;<sup>KO</sup> (bottom panels) mice at E18.5 (left) and P0 (right) stages. (G) Number of TUNEL<sup>&#x002B;</sup> cells within the CB (TH<sup>&#x002B;</sup> area) of HIF-2&#x03B1;<sup>WT</sup> (E18.5, n = 9; P0, n = 5) and TH-HIF-2&#x03B1;<sup>KO</sup> (E18.5, n = 5; P0, n = 4) mice at E18.5 and P0 stages. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001. Scale bars: 50 &#x03BC;m</p>
</caption>
<graphic xlink:href="250928_fig2.tif"/>
</fig>
<p>Consistent with the results described above (<xref rid="fig1" ref-type="fig">Figure 1C</xref>), the SCG volume was not different in mutant newborns relative to wild type controls (<xref rid="fig2" ref-type="fig">Figure 2E</xref>). We next assessed cell death in the developing CB, and found a progressive increase in the number of TUNEL<sup>&#x002B;</sup> cells within the CB parenchyma of TH-HIF-2&#x03B1;<sup>KO</sup> mice compared to HIF-2&#x03B1;<sup>WT</sup> littermates (<xref rid="fig2" ref-type="fig">Figure 2F and G</xref>). These data demonstrate that HIF-2&#x03B1;, but not HIF-1&#x03B1;, is essential for the differentiation of CB glomus cells.</p>
</sec>
<sec id="s2b">
<title>Impaired ventilatory response and whole-body metabolic activity in TH-HIF-2&#x03B1;<sup>KO</sup> mice exposed to hypoxia</title>
<p>Although TH-HIF-2&#x03B1;<sup>KO</sup> deficient mice did not show an apparent phenotype in the AM or SCG, it was important to determine whether their secretory or electrical properties were altered (<xref rid="figS3a" ref-type="fig">Figure 3-figure supplement 1</xref>). The secretory activity of chromaffin cells under basal conditions and in response to hypoxia, hypercapnia and high (20mM) extracellular K<sup>&#x002B;</sup> was not changed in TH-HIF-2&#x03B1;<sup>KO</sup> mice (8-12 weeks old) relative to control littermates (<xref rid="figS3a" ref-type="fig">Figure 3-figure supplement 1A-D</xref>). Current-voltage (I-V) relationships for Ca<sup>2&#x002B;</sup> and K<sup>&#x002B;</sup> currents of dispersed chromaffin cells (<xref rid="figS3a" ref-type="fig">Figure 3-figure supplement 1E</xref>) and SCG neurons (<xref rid="figS3a" ref-type="fig">Figure 3-figure supplement 1F</xref>) were also similar in HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> animals. These data further support the notion that HIF-2&#x03B1; loss in the sympathoadrenal lineages predominantly affects CB glomus cells.</p>
<p>To study the impact of the TH-HIF-2&#x03B1;<sup>KO</sup> mutation on respiratory function, we examined ventilation in normoxia (21&#x0025; O<sub>2</sub>) and in response to environmental normobaric hypoxia (10&#x0025; O<sub>2</sub>) via whole-body plethysmography. <xref rid="fig3" ref-type="fig">Figure 3A</xref> illustrates the changes of respiratory rate during a prolonged hypoxic time-course in HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> littermates. HIF-2&#x03B1;<sup>WT</sup> mice breathing 10&#x0025; O<sub>2</sub> had a biphasic response, characterized by an initial rapid increase in respiratory rate followed by a slow decline. In contrast, TH-HIF-2&#x03B1;<sup>KO</sup> mice, which have normal ventilation rates in normoxia (<xref rid="fig3" ref-type="fig">Figure 3A-C</xref>), respond abnormally throughout the hypoxic period. Averaged respiratory rate and minute volume during the initial 5 minutes of hypoxia show a substantial reduction in ventilation rate in TH-HIF-2&#x03B1;<sup>KO</sup> mutant mice relative to HIF-2&#x03B1;<sup>WT</sup> controls (<xref rid="fig3" ref-type="fig">Figure 3B</xref> and <xref rid="fig3" ref-type="fig">C</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption>
<p>Effects of HIF-2&#x03B1; and HIF-1&#x03B1; sympathoadrenal loss on the HVRand whole-body metabolic activity in response to hypoxia. (A and E) HVR in TH-HIF-2&#x03B1;<sup>KO</sup> (A, red line, n = 4) and TH-HIF-1&#x03B1;<sup>KO</sup> (E, blue line, n = 3) deficient mice compared to control HIF-2&#x03B1;<sup>WT</sup> (A, black line, n = 4) and HIF-1&#x03B1;<sup>WT</sup> (E, black line, n = 3) mice. Shift and duration of 10&#x0025; O<sub>2</sub> stimulus (30 minutes) are indicated. Shaded areas represent the period of time analysed in B and C or F and G, respectively. Data are presented as mean breaths/min every minute &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;p &#x003C; 0.01, ns, non-significant. (B and C) Averaged respiratory rate (B) and minute volume (C) of HIF-2&#x03B1;<sup>WT</sup> (black, n = 4) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 4) mice before and during the first 5 minutes of 10&#x0025; O<sub>2</sub> exposure (shaded rectangle in A). Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. (D) Peripheral O<sub>2</sub> saturation before, during and after hypoxia in HIF-2&#x03B1;<sup>WT</sup> (black, n = 8) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 9) mice. Data are expressed as mean percentage every 10 seconds &#x00B1;SEM. Two-way ANOVA,&#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001. (F and G) Averaged respiratory rate (F) and minute volume (F) of HIF-1&#x03B1;<sup>WT</sup> (black, n = 3) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue, n = 3) mice before and during the first 5 minutes of 10&#x0025; O<sub>2</sub> exposure (shaded rectangle in E). Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01. (H and I) Baseline metabolic activity of HIF-2&#x03B1;<sup>WT</sup> (black, n = 3) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 3) mice. Data are presented as mean oxygen consumption (VO<sub>2</sub>, H) and carbon dioxide generation (VCO<sub>2</sub>, I) every hour &#x00B1; SEM. White and black boxes depict diurnal and nocturnal periods, respectively. Area under the curve followed by Mann-Whitney test, ns, non-significant. (J and K) Whole-body metabolic analysis of HIF-2&#x03B1;<sup>WT</sup> (black, n = 4) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 6) mice in response to 10&#x0025; O<sub>2</sub>. Shift and duration of 10&#x0025; O<sub>2</sub> stimulus are indicated. Data are presented as mean oxygen consumption (VO<sub>2</sub>, J) and carbon dioxide generation (VCO<sub>2</sub>, K) every hour &#x00B1; SEM. White and black boxes depict diurnal and nocturnal periods, respectively. Recovery across the hypoxia period was analysed by one-phase association curve fitting. &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001.</p>
</caption>
<graphic xlink:href="250928_fig3.tif"/>
</fig>
<p>Additional respiratory parameters altered by the lack of CB in response to hypoxia are shown in <xref rid="fig3" ref-type="fig">Figure 3</xref>-supplement 2. Consistent with these data, hemoglobin saturation levels dropped to 50-55&#x0025; in TH-HIF-2&#x03B1;<sup>KO</sup> mice, as compared to 73&#x0025; saturation in control animals after exposure to 10&#x0025; O<sub>2</sub> for 5 minutes (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). HIF-1&#x03B1;<sup>WT</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> mice have similar respiratory responses to 21&#x0025; O<sub>2</sub> and 10&#x0025; O<sub>2</sub>, which indicates that HIF-1&#x03B1; is not required for the CB-mediated ventilatory response to hypoxia (<xref rid="fig3" ref-type="fig">Figure 3E-G</xref>; <xref rid="figS3b" ref-type="fig">Figure 3-supplemental 2F-J</xref>).</p><p>We next determined metabolic activity in HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> littermates in a 21&#x0025; O<sub>2</sub> or 10&#x0025; O<sub>2</sub> environment. Circadian metabolic profiles (VO<sub>2</sub> and VCO<sub>2</sub>) were similar in WT and TH-HIF-2&#x03B1;<sup>KO</sup> mutant mice (<xref rid="fig3" ref-type="fig">Figure 3H and I</xref>). After exposure to hypoxia, however, TH-HIF-2&#x03B1;<sup>KO</sup> mice showed lower VO<sub>2</sub> and VCO<sub>2</sub> peaks and had a significantly hampered metabolic adaptation to low oxygen (<xref rid="fig3" ref-type="fig">Figure 3J and K</xref>).</p>
</sec>
<sec id="s2c">
<title>Deficient acclimatization to chronic hypoxia in mice with CBs loss</title>
<p>The CB grows and expands during sustained hypoxia, due to the proliferative response of glia-like (GFAP<sup>&#x002B;</sup>) neural crest-derived stem cells within the CB parenchyma (<xref rid="c2" ref-type="bibr">Arias-Stella &#x0026; Valcarcel, 1976</xref>; <xref rid="c40" ref-type="bibr">Pardal et al., 2007)</xref>. Despite the absence of adult TH<sup>&#x002B;</sup> oxygen sensing cells in TH-HIF-2&#x03B1;<sup>KO</sup> mice, we identified a normal number of CB GFAP<sup>&#x002B;</sup> stem cells in the carotid artery bifurcation of these animals (<xref rid="figS4a" ref-type="fig">Figure 4-figure supplement 1A</xref>). We then determined the rate at which CB progenitors from TH-HIF-2&#x03B1;<sup>KO</sup> mice were able to give rise to newly formed CB TH<sup>&#x002B;</sup> glomus cells after chronic hypoxia exposition <italic>in vivo</italic>. Typical CB enlargement and emergence of double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> glomus cells was seen in HIF-2&#x03B1;<sup>WT</sup> mice after 14 days breathing 10&#x0025; O<sub>2</sub> (<xref rid="figS4a" ref-type="fig">Figure 4-figure supplement 1B-D</xref>), as previously described (<xref rid="c40" ref-type="bibr">Pardal et al., 2007)</xref>. However, no newly formed double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> glomus cells were observed in TH-HIF-2&#x03B1;<sup>KO</sup> mice after 14 days in hypoxia (<xref rid="figS4a" ref-type="fig">Figure 4-figure supplement 1B-D</xref>). These observations are consistent with the documented role of CB glomus cells as activators of the CB progenitors proliferation in response to hypoxia (<xref rid="c46" ref-type="bibr">Platero-Luengo et al., 2014)</xref>.</p>
<p>HIF-2&#x03B1;<sup>WT</sup>, HIF-1&#x03B1;<sup>WT</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> mice adapted well and survived up to 21 days in a 10&#x0025; O<sub>2</sub> atmosphere normally. However, long-term survival of the TH-HIF-2&#x03B1;<sup>KO</sup> deficient mice kept in a 10&#x0025; O<sub>2</sub> environment was severely compromised, and only 40&#x0025; reached the experimental endpoint (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). Mouse necropsies revealed internal general haemorrhages, which are most likely the cause of the death. TH-HIF-2&#x03B1;<sup>KO</sup> mice also showed increased haematocrit and haemoglobin levels relative to HIF-2&#x03B1;<sup>WT</sup> littermates when maintained for 21 days in a 10&#x0025; O<sub>2</sub> atmosphere (<xref rid="fig4" ref-type="fig">Figure 4B</xref> and <xref rid="fig4" ref-type="fig">C</xref>). Consistent with this, after 21 days in hypoxia, heart and spleen removed from TH-HIF-2&#x03B1;<sup>KO</sup> mice were enlarged relative to HIF-2&#x03B1;<sup>WT</sup> littermates, likely due to increased blood viscosity and extramedullary hematopoiesis, respectively (<xref rid="fig4" ref-type="fig">Figure 4D</xref> and <xref rid="fig4" ref-type="fig">E</xref>). TH-HIF-1&#x03B1;<sup>KO</sup> mice did not show significant differences compared to HIF-1&#x03B1;<sup>WT</sup> littermates maintained either in a 21&#x0025; O<sub>2</sub> or 10&#x0025; O<sub>2</sub> environment (<xref rid="figS4b" ref-type="fig">Figure 4-figure supplement 2A-D</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption>
<p>Impaired acclimatisation to chronic hypoxia and severe pulmonary hypertension in mice lacking CBs. (A) Kaplan-Meier survival curve of the indicated mice housed at 10&#x0025; O<sub>2</sub> up to 21 days. HIF-2&#x03B1;<sup>WT</sup> (n = 12), TH-HIF-2&#x03B1;<sup>KO</sup> (n = 11), HIF-1&#x03B1;<sup>WT</sup> (n = 8) and TH-HIF-1&#x03B1;<sup>KO</sup> (n = 8). &#x002A;&#x002A;&#x002A;p &#x003C; 0.001. (B and C) Haematocrit (B) and haemoglobin (C) levels of HIF-2&#x03B1;<sup>WT</sup> (black) and TH-HIF-2&#x03B1;<sup>KO</sup> (red) littermates kept in normoxia (21&#x0025; O<sub>2</sub>) and after 21 days at 10&#x0025; O<sub>2</sub>. In B, HIF-2&#x03B1;<sup>WT</sup> (21&#x0025; O<sub>2</sub>, n = 6; 10&#x0025; O<sub>2</sub>, n = 21), TH-HIF-2&#x03B1;<sup>KO</sup> (21&#x0025; O<sub>2</sub>, n = 7; 10&#x0025; O<sub>2</sub>, n = 8). In C, HIF-2&#x03B1;<sup>WT</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub>, n = 8), TH-HIF-2&#x03B1;<sup>KO</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub>, n = 7). Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. (D and E) Normalized heart (D) and spleen (E) weight of HIF-2&#x03B1;<sup>WT</sup> (black) and TH-HIF-2&#x03B1;<sup>KO</sup> (red) before and after 21 days in hypoxia (10&#x0025; O<sub>2</sub>). In D, HIF-2&#x03B1;<sup>WT</sup> (21&#x0025; O<sub>2</sub>, n = 16; 10&#x0025; O<sub>2</sub>, n = 23), TH-HIF-2&#x03B1;<sup>KO</sup> (21&#x0025; O<sub>2</sub>, n = 15; 10&#x0025; O<sub>2</sub>, n = 13). In E, HIF-2&#x03B1;<sup>WT</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub>, n = 23), TH-HIF-2&#x03B1;<sup>KO</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub>, n = 13). Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. (F) Fulton index on hearts dissected from HIF-2&#x03B1;<sup>WT</sup> (black, 21&#x0025; O<sub>2</sub>, n = 17; 10&#x0025; O<sub>2</sub>, n = 23) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, 21&#x0025; O<sub>2</sub>, n = 15; 10&#x0025; O<sub>2</sub>, n = 17) mice before and after 21 days in hypoxia (10&#x0025; O<sub>2</sub>). Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. RV, right ventricle. LV, left ventricle. (G) Right ventricular systolic pressure (RVSP) recorded on HIF-2&#x03B1;<sup>WT</sup> (black, 21&#x0025; O<sub>2</sub>, n = 6; 10&#x0025; O<sub>2</sub>, n = 7) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, 21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub>, n = 5) mice maintained in normoxia (21&#x0025; O<sub>2</sub>) or hypoxia (10&#x0025; O<sub>2</sub>) for 21 days. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. (H and I) Lung peripheral vessels muscularization (H) and arterial medial thickness (I) in HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> mice exposed to 10&#x0025; O<sub>2</sub> for 14 and/or 21 days. In H, HIF-2&#x03B1;<sup>WT</sup> (10&#x0025; O<sub>2</sub> 14d, n = 4; 10&#x0025; O<sub>2</sub> 21d, n = 3), TH-HIF-2&#x03B1;<sup>KO</sup> (10&#x0025; O<sub>2</sub> 14d, n = 6; 10&#x0025; O<sub>2</sub> 21d, n = 3). In I, HIF-2&#x03B1;<sup>WT</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub> 21d, n = 8), TH-HIF-2&#x03B1;<sup>KO</sup> (21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub> 21d, n = 8). Data are expressedas mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_fig4.tif"/>
</fig>
<p>Chronic exposure to hypoxia induces pulmonary arterial hypertension (PAH) in mice (<xref rid="c8" ref-type="bibr">Cowburn et al., 2016</xref>; <xref rid="c53" ref-type="bibr">Stenmark, Meyrick, Galie, Mooi, &#x0026; McMurtry, 2009</xref>). The right ventricle was found to be significantly enlarged in TH-HIF-2&#x03B1;<sup>KO</sup> mice relative to control mice after 21 days of 10&#x0025; O<sub>2</sub> exposure, indicating an aggravation of pulmonary hypertension (<xref rid="fig4" ref-type="fig">Figure 4F</xref>). This result was further confirmed by direct measurement of right ventricular systolic pressure (RVSP) on anaesthetised mice (<xref rid="fig4" ref-type="fig">Figure 4G</xref>). Lung histology of mice chronically exposed to 10&#x0025; O<sub>2</sub> (<xref rid="fig4" ref-type="fig">Figure 4H</xref>) shows that the percentage of fully muscularized lung peripheral vessels is significantly increased in TH-HIF-2&#x03B1;<sup>KO</sup> mice relative to controls. The tunica media of lung peripheral vessels was also significantly thicker in TH-HIF-2&#x03B1;<sup>KO</sup> mice compared to HIF-2&#x03B1;<sup>KO</sup> littermates after 21 days of hypoxic exposure (<xref rid="fig4" ref-type="fig">Figure 4I</xref>). Taken together, these data demonstrate that pulmonary adaptation to chronic hypoxia is highly reliant on a normally functioning CB.</p>
</sec>
<sec id="s2d">
<title>Cardiovascular homeostasis is altered in mice lacking CBs</title>
<p>An important element of the CB chemoreflex is an increase in sympathetic outflow (<xref rid="c32" ref-type="bibr">Lopez-Barneo, Ortega-Saenz, et al., 2016</xref>). To determine whether this had been affected in TH-HIF-2&#x03B1;<sup>KO</sup> mutants, cardiovascular parameters were recorded on unrestrained mice by radiotelemetry. Circadian blood pressure monitoring showed a constitutive hypotensive condition that was more pronounced during the diurnal period (<xref rid="fig5" ref-type="fig">Figure 5A</xref> and <xref rid="fig5" ref-type="fig">B</xref>) and did not correlate with changes in heart rate, subcutaneous temperature or activity (<xref rid="fig5" ref-type="fig">Figure 5C</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1A and B</xref>). We next subjected radiotelemetry-implanted HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> littermates to a 10&#x0025; O<sub>2</sub> environment preceded and followed by a 24 hour period of normoxia (<xref rid="fig5" ref-type="fig">Figure 5D-F</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1C-E</xref>). Normal control HIF-2&#x03B1;<sup>WT</sup> mice have a triphasic response to this level of hypoxia, characterised by a short (10 minutes) initial tachycardia and hypertension, followed by a marked drop both in heart rate and blood pressure; a partial to complete recovery is then seen after 24-36 hours (<xref rid="fig5" ref-type="fig">Figure 5D and E</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1C and D</xref>)(<xref rid="c9" ref-type="bibr">Cowburn, Macias, Summers, Chilvers, &#x0026; Johnson, 2017</xref>). However, while TH-HIF-2&#x03B1;<sup>KO</sup> mice experienced similar, but less deep, hypotension 3 hours post hypoxic challenge, they failed to recover, and showed a persistent hypotensive state throughout the hypoxic period (<xref rid="fig5" ref-type="fig">Figure 5D</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1C and D</xref>). Interestingly, the bradycardic effect of hypoxia on heart rate was abolished in TH-HIF-2&#x03B1;<sup>KO</sup> animals (<xref rid="fig5" ref-type="fig">Figure 5E</xref>). Subcutaneous temperature, an indirect indicator of vascular resistance in the skin, showed an analogous trend to that seen in the blood pressure of TH-HIF-2&#x03B1;<sup>KO</sup> mutants (<xref rid="fig5" ref-type="fig">Figure 5F</xref>). Activity of TH-HIF-2&#x03B1;<sup>KO</sup> mice during hypoxia was slightly reduced relative to littermate controls (<xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1E</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption>
<p>Effects of CB dysfunction on blood pressure regulation. (A-C) Circadian variations in baseline systolic blood pressure (A, continued line), diastolic blood pressure (A, broken line), mean blood pressure (B) and heart rate (C) of HIF-2&#x03B1;<sup>WT</sup> (black, n = 10) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 8) littermates recorded by radiotelemetry. White and black boxes depict diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test are shown. BP, blood pressure. HR, heart rate in beats per minute. (D-F) Mean blood pressure (D), heart rate (E) and subcutaneous temperature (F) alteration in response to hypoxia in radiotelemetry-implanted TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 5) compared to HIF-2&#x03B1;<sup>WT</sup> (black, n = 5). Shift and duration of 10&#x0025; O<sub>2</sub> are indicated in the graph. White and black boxes represent diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Recovery across the hypoxia period was analysed by one-phase association curve fitting. BP, blood pressure. HR, heart rate in beats per minute. (G) Schematic representation of the protocol followed in the Ang II-induced experimental hypertension model. (H-M) Mean blood pressure and heart rate recorded from HIF-2&#x03B1;<sup>WT</sup> (black, n = 8) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 8) mice after 7 days (H and K), 14 days (I and L) and 21 days (J and M) of Ang II infusion. White and black boxes depict diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test are shown. BP, blood pressure. HR, heart rate in beats per minute.</p>
</caption>
<graphic xlink:href="250928_fig5.tif"/>
</fig>
<p>The carotid body has been proposed as a therapeutic target for neurogenic hypertension (<xref rid="c38" ref-type="bibr">McBryde et al., 2013</xref>; <xref rid="c45" ref-type="bibr">Pijacka et al., 2016)</xref>. To determine the relationship between CB and hypertension in these mutants, we performed blood pressure recordings in an angiotensin II (Ang II)-induced experimental hypertension model (<xref rid="fig5" ref-type="fig">Figure 5G</xref>). As shown, TH-HIF-2&#x03B1;<sup>KO</sup> animals showed lower blood pressure relative to HIF-2&#x03B1;<sup>WT</sup> littermate controls after 7 days of Ang II infusion (<xref rid="fig5" ref-type="fig">Figure 5H</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1F and G</xref>). Heart rate, subcutaneous temperature and physical activity were unchanged throughout the experiment (<xref rid="fig5" ref-type="fig">Figure 5K-M</xref>; <xref rid="figS5a" ref-type="fig">Figure 5-figure supplement 1</xref>). Collectively, these data highlight the CB as a systemic cardiovascular regulator which, contributes to baseline blood pressure modulation, is critical for cardiovascular adaptations to hypoxia and delays the development of Ang II-induced experimental hypertension.</p>
</sec>
<sec id="s2e">
<title>Adaptive responses to exercise and high glucose are affected in mice with CB dysfunction</title>
<p>We next questioned whether this mutant, which lacks virtually all CB function, can inform questions about adaptation to other physiological stressors. In the first instance, we assessed metabolic activity during a maximal exertion exercise test. Oxygen consumption and carbon dioxide production (VO<sub>2</sub> and VCO<sub>2</sub>, respectively) were comparable in HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> mice at the beginning of the test. However, TH-HIF-2&#x03B1;<sup>KO</sup> mutants reached VO<sub>2</sub>max much earlier than wild type controls, with significantly decreased heat generation (<xref rid="fig6" ref-type="fig">Figure 6A, B and D</xref>). There was no shift in energetic substrate usage, as evidenced by the lack of difference in respiratory exchange ratio (RER) (<xref rid="fig6" ref-type="fig">Figure 6C</xref>). The time to exhaustion trended lower in mutants, and there was a significant reduction in both aerobic capacity and power output relative to littermate controls (<xref rid="fig6" ref-type="fig">Figure 6E-G</xref>). Interestingly, although no significant changes were found in glucose blood content across the experimental groups and conditions (<xref rid="fig6" ref-type="fig">Figure 6H</xref>), lactate levels in TH-HIF-2&#x03B1;<sup>KO</sup> mice were significantly lower than those observed in HIF-2&#x03B1;<sup>WT</sup> mice after running (<xref rid="fig6" ref-type="fig">Figure 6I</xref>).</p><p>We next examined the response of TH-HIF-2&#x03B1;<sup>KO</sup> mice to hyperglycemic and hypoglycemic challenge. Baseline glucose levels of HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> animals were not statistically different under fed and fasting conditions (<xref rid="fig6" ref-type="fig">Figure 6J and K</xref>), and metabolic activity during fasting was unaffected (<xref rid="figS6a" ref-type="fig">Figure 6-figure supplement 1A-D</xref>). However, TH-HIF-2&#x03B1;<sup>KO</sup> mutant mice showed significant changes in glucose tolerance, with no change in insulin tolerance when compared to HIF-2&#x03B1;<sup>WT</sup> littermates (<xref rid="fig6" ref-type="fig">Figure 6L and M</xref>). TH-HIF-2&#x03B1;<sup>KO</sup> mice also showed an initially hampered lactate clearance relative to control mice (<xref rid="fig6" ref-type="fig">Figure 6N</xref>). Together, these data demonstrate that the mutants demonstrate intriguing roles for the CB in metabolic adaptations triggered by both exercise and hyperglycemia.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption>
<p>Exercise performance and glucose management in mice lacking CBs. (A-D). Time course showing the increment in O<sub>2</sub> consumption (A), increment in CO<sub>2</sub> generation (B), respiratory exchange ratio (C) and increment in heat production (D) from HIF-2&#x03B1;<sup>WT</sup> (black, n = 8) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 10) mice during exertion on a treadmill. Mice were warmed up for 5 minutes (5m/min) and then the speed was accelerated 2m/min at 2.5 minutes intervals until exhaustion. Averaged measurements every 2.5 minutes intervals &#x00B1;SEM are charted. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001. RER, respiratory exchange ratio. (E) Running total time spent by HIF-2&#x03B1;<sup>WT</sup> (black, n = 8) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 10) mice to become exhausted. Data are expressed as mean &#x00B1;SEM. Unpaired t-test. (F and G) Aerobic capacity (F) and power output (G) measured in HIF-2&#x03B1;<sup>WT</sup> (black, n = 8) mice compared to TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 10) mice when performing at VO<sub>2</sub>max. Data are expressed as mean &#x00B1;SEM. Unpaired t-test. &#x002A;p &#x003C; 0.05. (H and I) Plasma glucose (H) and lactate (I) levels of HIF-2&#x03B1;<sup>WT</sup> (black, before, n = 7; after, n = 12) and TH-HIF-2&#x03B1;<sup>KO</sup> (black, before, n = 6;after, n = 12) littermates before and after running to exhaustion. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05. &#x002A;&#x002A;&#x002A;p &#x003C; 0.001. ns, non-significant. (J and K) Plasma glucose levels of HIF-2&#x03B1;<sup>WT</sup> (black, n = 6) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 6) mice fed (J, n = 6 per genotype) or fasted over night (K, HIF-2&#x03B1;<sup>WT</sup> (n = 8) and TH-HIF-2&#x03B1;<sup>KO</sup> (n = 10). Data are expressed as mean &#x00B1;SEM. Unpaired t-test. (L-M) Time courses showing the tolerance of HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> mice to glucose (L, n = 7 per genotype) insulin (M, n = 11 per genotype) and lactate (N, n = 7 per genotype) injected bolus. Data are presented as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_fig6.tif"/>
</fig>
</sec>
<sec id="s2f">
<title>CB development and proliferation in response to hypoxia require mTORC1 activation</title>
<p>Hypoxia is an mTORC1 activator that can induce cell proliferation and growth in a number of organs, e.g., the lung parenchyma (<xref rid="c4" ref-type="bibr">Brusselmans et al., 2003</xref>; <xref rid="c8" ref-type="bibr">Cowburn et al., 2016</xref>; <xref rid="c11" ref-type="bibr">Elorza et al., 2012</xref>; <xref rid="c19" ref-type="bibr">Hubbi &#x0026; Semenza, 2015</xref>; <xref rid="c57" ref-type="bibr">Torres-Capelli et al., 2016)</xref>. Physiological proliferation and differentiation of the CB induced by hypoxia closely resembles CB developmental expansion (<xref rid="c1" ref-type="bibr">Annese et al., 2017</xref>; <xref rid="c40" ref-type="bibr">Pardal et al., 2007</xref>; <xref rid="c46" ref-type="bibr">Platero-Luengo et al., 2014)</xref>; therefore a potential explanation for the developmental defects in CB expansion observed in above could be defects in mTORC1 activation.</p>
<p>To test this hypothesis, we first determined mTORC1 activation levels in the CB of mice maintained at 21&#x0025; O<sub>2</sub> or 10&#x0025; O<sub>2</sub> for 14 days. This was done via immunofluorescent detection of the phosphorylated form of the ribosomal protein S6 (p-S6) (<xref rid="c11" ref-type="bibr">Elorza et al., 2012</xref>; <xref rid="c34" ref-type="bibr">Ma &#x0026; Blenis, 2009)</xref>. In normoxia, there was a faint p-S6 expression within the TH<sup>&#x002B;</sup> glomus cells of the CB in wild type mice; this contrasts with the strong signal detected in SCG sympathetic neurons (<xref rid="fig7" ref-type="fig">Figure 7A</xref>, left panels; <xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1A</xref>, left panel). However, after 14 days in a 10&#x0025; O<sub>2</sub> environment, we saw a significantly increased p-S6 signal within the CB TH<sup>&#x002B;</sup> cells while the SCG sympathetic neurons remained at levels similar to those seen in normoxia (<xref rid="fig7" ref-type="fig">Figure 7A and B</xref>; <xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1A and B</xref>). TH expression, which is induced by hypoxia (<xref rid="c50" ref-type="bibr">Schnell et al., 2003)</xref>, was also significantly elevated in CB TH<sup>&#x002B;</sup> cells, and trended higher in SCG sympathetic neurons (<xref rid="fig7" ref-type="fig">Figure 7B</xref>; <xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1B</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><p>mTORC1 activation in CB development and hypoxia-induced CB neurogenesis. (A) Double TH and p-S6 (mTORC1 activation marker) immunofluorescence on adult wild type CB slices to illustrate the increased p-S6 expression after 14 days in hypoxia (10&#x0025; O<sub>2</sub>). For clarity, bottom panels only show p-S6 staining. TH<sup>&#x002B;</sup> outlined area (top panels) indicates the regionused for pixels quantification. Scale bars: 50 &#x00B5;m. (B) Quantification of p-S6 (top) and TH (bottom) mean pixels intensity within the CB TH<sup>&#x002B;</sup> cells of wild type mice breathing 21&#x0025; O<sub>2</sub> or 10&#x0025; O<sub>2</sub> for 14 days. Each data point depicts the average of 3-4 pictures. 21&#x0025; O<sub>2</sub>, n = 5; 10&#x0025; O<sub>2</sub> 14d, n = 9 per genotype. Data are presented as mean &#x00B1;SEM. Unpaired t-test, &#x002A;p &#x003C; 0.05. (C) Representative micrographs of TH and p-S6 double immunostaining of HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> embryonic (E18.5) carotid bifurcations. TH<sup>&#x002B;</sup> outlined area indicates the region used for pixels quantification. Scale bars: 50&#x00B5;m. (D) Quantitative analysis performed on HIF-2&#x03B1;<sup>WT</sup> (black, n = 12) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 10) micrographs previously immuno-stained for p-S6 and TH. Each data point depicts the average of 3-4 pictures. Data are presented as mean &#x00B1;SEM. Unpaired t-test, &#x002A;&#x002A;p &#x003C; 0.01. (E) Double BrdU and TH immunofluorescence on carotid bifurcation sections from wild type mice exposed to 10&#x0025; O<sub>2</sub> and injected with rapamycin or vehicle control for 14 days. Notice the striking decrease in double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> cells (white arrowheads) in the rapamycin treated mice compared to vehicle control animals. Scale bars: 100&#x00B5;m. (F-H) Quantification of total CB volume (F), TH<sup>&#x002B;</sup> cells number (G) and percentage of double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> over the total TH<sup>&#x002B;</sup> cells (H) in wild type mice breathing 10&#x0025; O<sub>2</sub> and injected with rapamycin or vehicle control for 14 days. n = 5 mice per treatment. (K) Averaged breaths per minute during the first 2 minutes of acute hypoxia (10&#x0025; O<sub>2</sub>) exposure from vehicle or rapamycin injected mice before and after 7 days of chronic hypoxia (10&#x0025; O<sub>2</sub>) treatment. n = 14 mice per condition and treatment. Data are presented as mean &#x00B1;SEM. B, D, F, G and H, unpaired t-test, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001. K, two-way ANOVA followed by Tukey&#x2019;s multiple comparison test. &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_fig7.tif"/>
</fig>
<p>We next assessed the role of HIF-2&#x03B1; in this hypoxia-induced mTORC1 activation. We began with evaluating expression of p-S6 in late stage embryos. In E18.5 embryos there was a striking accumulation of p-S6; this is significantly reduced in HIF-2&#x03B1; deficient CB TH<sup>&#x002B;</sup> cells in embryos from this stage of development (<xref rid="fig7" ref-type="fig">Figure 7C and D</xref>). p-S6 levels in SCG TH<sup>&#x002B;</sup> sympathetic neurons of HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> E18.5 embryos were unaffected, however (<xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1C and D</xref>).</p>
<p>TH expression trended lower in both CB and SCG TH<sup>&#x002B;</sup> cells from TH-HIF-2&#x03B1;<sup>KO</sup> E18.5 embryos relative to HIF-2&#x03B1;<sup>WT</sup> littermate controls (<xref rid="fig7" ref-type="fig">Figure 7D</xref>; <xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1D</xref>). These data indicate that HIF-2&#x03B1; regulates mTORC1 activity in the CB glomus cells during development. To determine whether this pathway could be pharmacologically manipulated, we then studied the effect of mTORC1 inhibition by rapamycin on CB proliferation and growth following exposure to environmental hypoxia. mTORC1 activity, as determined by p-S6 staining on SCG and CB TH<sup>&#x002B;</sup> cells after 14 days of hypoxic treatment, was inhibited after <italic>in vivo</italic> rapamycin administration (<xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1E</xref>). Interestingly, histological analysis of rapamycin injected wild type mice maintained for 14 days at 10&#x0025; O<sub>2</sub> showed decreased CB parenchyma volume, TH<sup>&#x002B;</sup> cells number, and showed a dramatic reduction in the number of proliferating double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> cells when compared to vehicle-injected mice (<xref rid="fig7" ref-type="fig">Figure 7E-H</xref>).</p>
<p>In addition, we assessed the ventilatory acclimatization to hypoxia (VAH), as a progressive increase in ventilation rates is associated with CB growth during sustained exposure to hypoxia (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>). Consistent with the histological analysis above, rapamycin treated mice had a decreased VAH compared to vehicle-injected control mice following 7 days at 10&#x0025; O<sub>2</sub> (<xref rid="fig7" ref-type="fig">Figure 7K</xref>). Haematocrit levels were comparable between vehicle control and rapamycing treated wild type mice after 7 days in hypoxia (<xref rid="figS7a" ref-type="fig">Figure 7-figure supplement 1F</xref>).</p>
<p>Collectively, these data indicate that mTORC1 activation is required for CB expansion in a HIF-2&#x03B1;-dependent manner, and this activation regulates CB growth and subsequent VAH under prolonged low pO<sub>2</sub> conditions.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Metabolic homeostasis depends on a complex system of O<sub>2</sub>-sensing cells and organs. The carotid body is central to this, via its regulation of metabolic and ventilatory responses to oxygen (<xref rid="c31" ref-type="bibr">Lopez-Barneo, Macias, Platero-Luengo, Ortega-Saenz, &#x0026; Pardal, 2016</xref>). At the cellular level, the HIF transcription factor is equally central for responses to oxygen flux. However, how HIF contributes to the development and function of CB O<sub>2</sub>-sensitivity is still not completely understood. Initial studies performed on global <italic>Hif-1&#x03B1;</italic><sup><italic>-/-</italic></sup> or <italic>Hif-2&#x03B1;</italic><sup><italic>-/-</italic></sup>mutant mice revealed that HIFs are critical for development (<xref rid="c7" ref-type="bibr">Compernolle et al., 2002</xref>; <xref rid="c21" ref-type="bibr">Iyer et al., 1998</xref>; <xref rid="c42" ref-type="bibr">J. Peng, Zhang, Drysdale, &#x0026; Fong, 2000</xref>; <xref rid="c47" ref-type="bibr">Ryan, Lo, &#x0026; Johnson, 1998</xref>; <xref rid="c51" ref-type="bibr">Scortegagna et al., 2003</xref>; <xref rid="c57" ref-type="bibr">Tian et al., 1998)</xref>, but only HIF-2&#x03B1;<sup>-/-</sup> embryos showed defects in catecholamine homeostasis, which indicated a potential role in sympathoadrenal development (<xref rid="c57" ref-type="bibr">Tian et al., 1998)</xref>.</p>
<p>Investigations using hemizygous <italic>Hif-1&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup> and <italic>Hif-2&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup> mice showed no changes in the CB histology or overall morphology (<xref rid="c25" ref-type="bibr">Kline et al., 2002</xref>; <xref rid="c43" ref-type="bibr">Y. J. Peng et al., 2011</xref>). However, our findings demonstrate that embryological deletion of <italic>Hif-2&#x03B1;</italic>, but not <italic>Hif-1&#x03B1;</italic>, specifically in sympathoadrenal tissues (TH<sup>&#x002B;</sup>) prevents O<sub>2</sub>-sensitive glomus cell development, without affecting SCG sympathetic neurons or AM chromaffin cells of the same embryological origin. It was previously reported that HIF-2&#x03B1;, but not HIF-1&#x03B1; overactivation in catecholaminergic tissues led to marked enlargement of the CB (<xref rid="c35" ref-type="bibr">Macias et al., 2014</xref>). Mouse models of Chuvash polycythemia, which have a global increase in HIF-2&#x03B1; levels, also show CB hypertrophy and enhanced acute hypoxic ventilatory response (<xref rid="c52" ref-type="bibr">Slingo, Turner, Christian, Buckler, &#x0026; Robbins, 2014</xref>). Thus either over-expression or deficiency of HIF-2&#x03B1; clearly perturbs CB development and, by extension, function.</p>
<p>Sustained hypoxia is generally thought to attenuate cell proliferation in a HIF-1&#x03B1;-dependent fashion (<xref rid="c6" ref-type="bibr">Carmeliet et al., 1998</xref>; <xref rid="c14" ref-type="bibr">Goda et al., 2003</xref>; <xref rid="c26" ref-type="bibr">Koshiji et al., 2004)</xref>. However, environmental hypoxia can also trigger growth of a number of specialized tissues, including the CB (<xref rid="c2" ref-type="bibr">Arias-Stella &#x0026; Valcarcel, 1976</xref>; <xref rid="c40" ref-type="bibr">Pardal et al., 2007)</xref> and the pulmonary arteries (<xref rid="c36" ref-type="bibr">Madden, Vadula, &#x0026; Kurup, 1992</xref>). In this context, the HIF-2&#x03B1; isoform seems to play the more prominent role, and has been associated with pulmonary vascular remodeling as well as with bronchial epithelial proliferation (<xref rid="c4" ref-type="bibr">Brusselmans et al., 2003</xref>; <xref rid="c5" ref-type="bibr">Bryant et al., 2016</xref>; <xref rid="c8" ref-type="bibr">Cowburn et al., 2016</xref>; <xref rid="c24" ref-type="bibr">Kapitsinou et al., 2016</xref>; <xref rid="c54" ref-type="bibr">Tan et al., 2013</xref>; <xref rid="c57" ref-type="bibr">Torres-Capelli et al., 2016)</xref>.</p>
<p>CB enlargement induced by hypoxia to a large extent recapitulates the cellular events that give rise to mature O<sub>2</sub>-sensitive glomus cells in development. In a recent study, global HIF-2&#x03B1;, but not HIF-1&#x03B1;, inactivation in adult mice was shown to impair CB growth and associated VAH caused by exposure to chronic hypoxia (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>). Therefore, we used this physiological proliferative response as a model to understand the developmental mechanisms underpinning of HIF-2&#x03B1; deletion in O<sub>2</sub>-sensitive glomus cells.</p>
<p>Contrasting effects of HIF-&#x03B1; isoforms on the mammalian target of rapamycin complex 1 (mTORC1) activity can be found in the literature that mirror the differential regulation of cellular proliferation induced by hypoxia in different tissues (see above) (<xref rid="c3" ref-type="bibr">Brugarolas et al., 2004</xref>; <xref rid="c11" ref-type="bibr">Elorza et al., 2012</xref>; <xref rid="c30" ref-type="bibr">Liu et al., 2006)</xref>. Our findings reveal that mTORC1, a central regulator of cellular metabolism, proliferation and survival (<xref rid="c27" ref-type="bibr">Laplante &#x0026; Sabatini, 2012)</xref>, is necessary for CB O<sub>2</sub>-sensitive glomus cell proliferation; and further, that impact in the subsequent enhancement of the hypoxic ventilatory response induced by chronic hypoxia. Importantly, we found that mTORC1 activity is reduced in HIF-2&#x03B1;-deficient embryonic glomus cells, but not in SCG sympathetic neurons, which likely explains the absence of a functional adult CB in these mutants.</p>
<p>As HIF-2&#x03B1; regulates mTORC1 activity to promote proliferation, this connection could prove relevant in pathological situations; e.g., both somatic and germline <italic>Hif-2&#x03B1;</italic> gain-of-function mutations have been found in patients with paraganglioma, a catecholamine-secreting tumor of neural crest origin (<xref rid="c33" ref-type="bibr">Lorenzo et al., 2013</xref>; <xref rid="c60" ref-type="bibr">Zhuang et al., 2012</xref>). Indeed, CB tumors are 10 times more frequent in people living at high altitude (<xref rid="c48" ref-type="bibr">Saldana, Salem, &#x0026; Travezan, 1973</xref>). As further evidence of this link, it has been shown that the mTOR pathway is commonly activated in both paraganglioma and pheochromocytoma tumors (<xref rid="c10" ref-type="bibr">Du et al., 2016</xref>; <xref rid="c12" ref-type="bibr">Favier, Amar, &#x0026; Gimenez-Roqueplo, 2015</xref>).</p>
<p>CB chemoreception plays a crucial role in homeostasis, particularly in regulating cardiovascular and respiratory responses to hypoxia. Our data show that mice lacking CB O<sub>2</sub>-sensitive cells (TH-HIF-2&#x03B1;<sup>KO</sup> mice) have impaired respiratory, cardiovascular and metabolic adaptive responses.</p>
<p>Although previous studies have linked HIF-2&#x03B1; and CB function (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>; <xref rid="c43" ref-type="bibr">Y. J. Peng et al., 2011</xref>), none of them exhibited a complete CB loss of function. This might explain the differing effects observed in hemizygous <italic>Hif-2&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup> mice (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>; <xref rid="c43" ref-type="bibr">Y. J. Peng et al., 2011</xref>) compared to our TH-HIF-2&#x03B1;<sup>KO</sup> mice.</p>
<p>Mice with a specific HIF-1&#x03B1; ablation in CB O<sub>2</sub>-sensitive glomus cells (TH-HIF-1&#x03B1;<sup>KO</sup> mice) did not show altered hypoxic responses in our experimental conditions. Consistent with this, hemizygous <italic>Hif-1&#x03B1;</italic><sup><italic>&#x002B;/-</italic></sup> mice exhibited a normal acute HVR (<xref rid="c18" ref-type="bibr">Hodson et al., 2016</xref>; <xref rid="c25" ref-type="bibr">Kline et al., 2002</xref>) albeit some otherwise aberrant CB activities in response to hypoxia (<xref rid="c25" ref-type="bibr">Kline et al., 2002</xref>; <xref rid="c39" ref-type="bibr">Ortega-Saenz, Pascual, Piruat, &#x0026; Lopez-Barneo, 2007</xref>).</p>
<p>Alterations in CB development and/or function have recently acquired increasing potential clinical significance and have been associated with diseases such as heart failure, obstructive sleep apnea, chronic obstructive pulmonary disease, sudden death infant syndrome and hypertension (<xref rid="c20" ref-type="bibr">Iturriaga, Del Rio, Idiaquez, &#x0026; Somers, 2016</xref>; <xref rid="c32" ref-type="bibr">Lopez-Barneo, Ortega-Saenz, et al., 2016</xref>).</p>
<p>We describe here the first mouse model with specific loss of carotid body O<sub>2</sub>-sensitive cells: a model that is viable in normoxia but shows impaired physiological adaptations to both acute and chronic hypoxia. In addition, we describe new and likely important roles for the CB in systemic blood pressure regulation, exercise performance and glucose management. Further investigation of this mouse model could aid in revealing roles of the carotid body in both physiology and disease.</p>
</sec>
<sec id="s4">
<title>Material and Methods</title>
<sec id="s4g">
<title>Mice husbandry</title>
<p>This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). Targeted deletion of <italic>Hif-1&#x03B1;</italic>, <italic>Hif-2&#x03B1;</italic> and <italic>Td-Tomato</italic> in sympathoadrenal tissues was achieved by crossing homozygous mice carrying loxP-flanked alleles <italic>Hif1a</italic><sup><italic>tm3Rsjo</italic></sup> (<xref rid="c47" ref-type="bibr">Ryan et al., 1998</xref>), <italic>Epas1</italic><sup><italic>tm1Mcs</italic></sup> (<xref rid="c15" ref-type="bibr">Gruber et al., 2007)</xref> or <italic>Gt(ROSA)26Sor</italic><sup><italic>tm9(CAG-tdTomato)Hze</italic></sup> (<xref rid="c37" ref-type="bibr">Madisen et al., 2010</xref>) into a mouse strain of <italic>cre</italic> recombinase expression driven by the endogenous tyrosine hydroxylase promoter (<italic>Th</italic><sup><italic>tm1(cre)Te</italic></sup>)(<xref rid="c29" ref-type="bibr">Lindeberg et al., 2004)</xref>, which is specific of catecholaminergic cells. LoxP-flanked littermate mice without cre recombinase (HIF-1&#x03B1;<sup>flox/flox</sup>, HIF-2&#x03B1;<sup>flox/flox</sup> or Td-Tomato<sup>flox/flox</sup>) were used as control group (HIF-1&#x03B1;<sup>WT</sup>, HIF-2&#x03B1;<sup>WT</sup> and Td-Tomato, respectively) for all the experiments. C57BL/6J wild type mice were purchased from The Jackson laboratory (Bar Harbor, Maine, US). All the experiments were performed with age and sex matched control and experimental mice.</p>
</sec>
<sec id="s4h">
<title>Tissue preparation, immunohistochemistry and morphometry</title>
<p>Newborn (P0) and adult mice (8-12 weeks old) were killed by an overdose of sodium pentobarbital injected intraperitoneally. E18.5 embryos were collected and submerged into a cold formalin solution (Sigma-Aldrich, Dorset, UK). The carotid bifurcation and adrenal gland, were dissected, fixed for 2 hours with 4&#x0025; paraformaldehyde (Santa Cruz Biotechnology) and cryopreserved (30&#x0025; sucrose in PBS) for cryosectioning (10 &#x03BC;m thick, Bright Instruments, Luton, UK). Tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), bromodeoxyuridine (BrdU) and phospho-S6 ribosomal protein (p-S6) were detected using the following polyclonal antibodies: rabbit anti-TH (1:5000, Novus Biologicals, Abindong, UK; NB300-109) for single immunofluorescence or chicken anti-TH (1:1000, abcam, Cambridge, UK; ab76442) for double immunofluorescence, rabbit anti-GFAP (1:500, Dako, Cambridge, UK; Z0334), rat anti-BrdU (1:100, abcam, ab6326), and rabbit anti-phospho-S6 ribosomal protein (1:200, Cell Signaling, 2211), respectively. Fluorescence-based detection was visualized using, Alexa-Fluor 488- and 568-conjugated anti-rabbit IgG (1:500, ThermoFisher, Waltham, MA US), Alexa-Fluor 488-conjugated anti-chicken IgG (1:500, ThermoFisher) and Alexa-Fluor 488-conjudaged anti-rat IgG (1:500, ThermoFisher) secondary antibodies. Chromogen-based detection was performed with Dako REAL Detection Systems, Peroxidase/DAB&#x002B;, Rabbit/Mouse (Dako, K5001) and counterstained with Carrazzi hematoxylin. For the Td-Tomato detection, carotid bifurcation and adrenal gland were dissected, embedded with OCT, flash-frozen into liquid N<sub>2</sub> and sectioned (10 &#x03BC;m thick, Bright Instruments). Direct Td-Tomato fluorescence was imaged after nuclear counterstain with 4',6-diamidino-2-phenylindole (DAPI).</p>
<p>CB glomus cell counting, area measurements and pixel mean intensity were calculated on micrographs (Leica DM-RB, Wetzlar, Gernany) taken from sections spaced 40 &#x03BC;m apart across the entire CB using Fiji software (<xref rid="c49" ref-type="bibr">Schindelin et al., 2012)</xref> as previously reported (<xref rid="c35" ref-type="bibr">Macias et al., 2014</xref>). CB and SCG volume was estimated on the same micrographs according to Cavalieri&#x2019;s principle. Lung tissue was removed in the distended state by infusion into the trachea of 0.8&#x0025; agarose and then fixed in 4&#x0025; paraformaldehyde for paraffin embedding. Lung sections (6 &#x03BC;m thick) were stained with H&#x0026;E and EVG stain to assess morphology (Merck, Darmstadt, Germany). Vessel medial thickness was measured on micrographs using Fiji software. To determine the degree of muscularization of small pulmonary arteries, serial lung tissue sections were stained with anti-&#x03B1; smooth muscle actin (1:200, Sigma-Aldrich, A2547). Tissue sections were independently coded and quantified by a blinded investigator.</p>
</sec>
<sec id="s4i">
<title>Gene deletion</title>
<p>Genomic DNA was isolated from dissected SCG and AM using DNeasy Blood &#x0026; Tissue Kit (Qiagen, Hilden, Germany). Relative gene deletion was assayed by qPCR (One-Step Plus Real-Time PCR System; ThermoFisher Scientific) using TaqMan&#x2122; Universal PCR Master Mix (ThermoFisher Scientific) and PrimeTime Std qPCR Assay (IDT, Coralville, IA US).</p>
<p>For Hif-1&#x03B1;,</p>
<p>Hif1_probe: 5&#x2019;-/56-FAM/CCTGTTGGTTGCGCAGCAAGCATT/3BHQ_1/-3&#x2019;</p>
<p>Hif1_F: 5&#x2019;-GGTGCTGGTGTCCAAAATGTAG-3&#x2019;</p>
<p>Hif1_R: 5&#x2019;-ATGGGTCTAGAGAGATAGCTCCACA-3&#x2019;</p>
<p>For Hif-2&#x03B1;,</p>
<p>Hif2_probe: 5&#x2019;-/56-FAM/CCACCTGGACAAAGCCTCCATCAT/3IABkFQ/-3&#x2019;</p>
<p>Hif2_F: 5&#x2019;-TCTATGAGTTGGCTCATGAGTTG-3&#x2019;</p>
<p>Hif2_R: 5&#x2019;-GTCCGAAGGAAGCTGATGG-3&#x2019;</p>
<p>Relative gene deletion levels were calculated using the 2&#x0394;&#x0394;CT method.</p>
</sec>
<sec id="s4j">
<title>Tissue preparation for amperometry and patch clamp experiments</title>
<p>Adrenal glands and SCG were quickly removed and transferred to ice-cooled PBS. Dissected AM was enzymatically dispersed in two steps. First, tissue was placed in 3 ml of extraction solution (in mM: 154 NaCl, 5.6 KCl, 10 Hepes, 11 glucose; pH 7.4) containing 425 U/ml collagenase type IA and 4-5 mg of bovine serum albumin (all from Sigma-Aldrich), and incubated for 30 min at 37&#x00B0;C. Tissue was mechanically dissociated every 10 minutes by pipetting. Then, cell suspension was centrifuged (165 g and 15-20&#x00BA;C for 4 min), and the pellet suspended in 3 ml of PBS containing 9550 U/ml of trypsin and 425 U/ml of collagenase type IA (all from Sigma-Aldrich). Cell suspension was further incubated at 37&#x00B0;C for 5 min and mechanically dissociated by pipetting. Enzymatic reaction was stopped by adding &#x2248;10 ml of cold complete culture medium (DMEM/F-12 (21331-020 GIBCO, ThermoFisher Scientific) supplemented with penicillin (100 U/ml)/streptomycin (10 &#x03BC;g/ml), 2 mM L-glutamine and 10&#x0025; fetal bovine serum. The suspension was centrifuged (165 g and 15-20&#x00BA;C for 4 min), the pellet gently suspended in 200 &#x03BC;l of complete culture medium. Next, cells were plated on small coverslips coated with 1 mg/ml poly-L-lysine and kept at 37&#x00BA;C in a 5&#x0025; CO<sub>2</sub> incubator for settlement. Afterwards, the petri dish was carefully filled with 2 ml of culture medium and returned to the incubator for 2 hours. Under these conditions, cells could be maintained up to 12-14 hours to perform experiments.</p>
<p>To obtain SCG dispersed cells, the tissue was placed in a 1.5 ml tube containing enzymatic solution (2.5 mg/ml collagenase type IA in PBS) and incubated for 15 min in a thermoblock at 37&#x00B0;C and 300 rpm. The suspension was mechanically dissociated by pipetting and centrifuged for 3 min at 200 g.</p>
<p>The pellet was suspended in the second enzymatic dispersion (1mg/ml of trypsin in PBS), incubated at 37&#x00B0;C, 300 rpm for 25 min and dissociated again with a pipette. Enzymatic reaction was stopped adding a similar solution than used for chromaffin cells (changing fetal bovine serum for newborn calf serum). Finally, dispersed SCG cells were plated onto poly-L-lysine coated coverslips and kept at the 37&#x00BA;C incubator. Experiments with SCG cells were done between 24-48h after finishing the culture.</p>
<p>To prepare AM slices, the capsule and adrenal gland cortex was removed and the AM was embedded into low melting point agarose at when reached 47 &#x00BA;C. The agarose block is sectioned (200 &#x03BC;m thick) in an O<sub>2</sub>-saturated Tyrode's solution using a vibratome (VT1000S, Leica). AM slices were washed twice with the recording solution (in mM: 117 NaCl, 4.5 KCl, 23 NaHCO<sub>3</sub>, 1 MgCl<sub>2</sub>, 1 CaCl<sub>2</sub>, 5 glucose and 5 sucrose) and bubbled with carbogen (5&#x0025; CO<sub>2</sub> and 95&#x0025; O<sub>2</sub>) at 37 &#x00BA;C for 30 min in a water bath. Fresh slices are used for the experiments during 4-5h after preparation.</p>
</sec>
<sec id="s4k">
<title>Patch-clamp recordings</title>
<p>The macroscopic currents were recorded from dispersed mouse AM and SCG cells using the whole cell configurations of the patch clamp technique. Micropipettes (&#x2248;3 M&#x03A9;) were pulled from capillary glass tubes (Kimax, Kimble Products, Rockwood, TN US) with a horizontal pipette puller (Sutter instruments model P-1000, Novato, CA US) and fire polished with a microforge MF-830 (Narishige, Amityville, NY US). Voltage-clamp recordings were obtained with an EPC-7 amplifier (HEKA Electronik, Lambrecht/Pfalz, Germany). The signal was filtered (3 kHz), subsequently digitized with an analog/digital converter (ITC-16 Instrutech Corporation, HEKA Electronik) and finally sent to the computer. Data acquisition and storage was done using the Pulse/pulsefit software (Heka Electronik) at a sampling interval of 10 &#x03BC;sec. Data analysis is performed with the Igor Pro Carbon (Wavemetrics, Portland, OR US) and Pulse/pulsefit (HEKA Electronik) programs. All experiments were conducted at 30-33&#x00B0;C. Macroscopic Ca<sup>2&#x002B;</sup>, Na<sup>&#x002B;</sup>, and K<sup>&#x002B;</sup> currents were recorded in dialyzed cells. The solutions used for the recording of Na<sup>&#x002B;</sup> and Ca<sup>2&#x002B;</sup> currents contained (in mM): external: 140 NaCl, 10 BaCl<sub>2</sub>, 2.5 KCl, 10 HEPES, and 10 glucose; pH 7.4 and osmolality 300 mOsm/kg; and internal: 110 CsCl, 30 CsF, 10 EGTA, 10 HEPES, and 4 ATP-Mg; pH 7.2 and osmolality 285 mOsm/kg. The external solution used for the recording of whole cell K<sup>&#x002B;</sup> currents was (in mM): 117 NaCl, 4.5 KCl, 23 NaHCO<sub>3</sub>, 1 MgCl<sub>2</sub>, 2.5 CaCl<sub>2</sub>, 5 glucose and 5 sucrose. The internal solution to record K<sup>&#x002B;</sup> currents was (in mM): 80 potassium glutamate, 50 KCl, 1 MgCl<sub>2</sub>, 10 HEPES, 4 MgATP, and 5 EGTA, pH 7.2. Depolarizing steps of variable duration (normally 10 or 50 msec) from a holding potential of &#x2212;70 mV to different voltages ranging from &#x2212;60 up to &#x002B;50 mV (with voltage increments of 10 mV) were used to record macroscopic ionic currents in AM and SCG cells.</p>
</sec>
<sec id="s4l">
<title>Amperometric recording</title>
<p>To perform the experiments, single slices were transferred to the chamber placed on the stage of an upright microscope (Axioscope, Zeiss, Oberkochen, Germany) and continuously perfused by gravity (flow 1&#x2013;2 ml min<sup><bold>-</bold></sup><sup>1</sup>) with a solution containing (in mM): 117 NaCl, 4.5 KCl, 23 NaHCO<sub>3</sub>, 1 MgCl<sub>2</sub>, 2.5 CaCl<sub>2</sub>, 5 glucose and 5 sucrose. The &#x2018;normoxic&#x2019; solution was bubbled with 5&#x0025; CO<sub>2</sub>, 20&#x0025; O<sub>2</sub> and 75 &#x0025; N<sub>2</sub> (PO<sub>2</sub> &#x2248; 150 mmHg). The &#x2018;hypoxic&#x2019; solution was bubbled with 5&#x0025; CO<sub>2</sub> and 95&#x0025; N<sub>2</sub> (PO<sub>2</sub> &#x2248; 10&#x2013;20 mmHg). The &#x2018;hypercapnic&#x2019; solution was bubbled with 20&#x0025; CO<sub>2</sub>, 20&#x0025; O<sub>2</sub> and 60 &#x0025; N<sub>2</sub> (PO<sub>2</sub> &#x2248; 150 mmHg). The osmolality of solutions was &#x2248; 300 mosmol kg<sup><bold>&#x2212;</bold></sup><sup>1</sup> and pH = 7.4. In the 20 mM K<sup>&#x002B;</sup> solution, NaCl was replaced by KCl equimolarly (20 mM). All experiments were carried out at a chamber temperature of 36<bold>&#x00B0;</bold>C. Amperometric currents were recorded with an EPC-8 patch-clamp amplifier (HEKA Electronics), filtered at 100 Hz and digitized at 250 Hz for storage in a computer. Data acquisition and analysis were carried out with an ITC-16 interface and PULSE/PULSEFIT software (HEKA Electronics). The secretion rate (fC min<sup>&#x2212;1</sup>) was calculated as the amount of charge transferred to the recording electrode during a given period of time.</p>
</sec>
<sec id="s4m">
<title>Catecholamine measurements</title>
<p>Catecholamine levels were determined by ELISA (Abnova, Taipei, Taiwan) following manufacture&#x2019;s instructions. Spontaneous urination was collected from control and experimental mice (8-12 weeks old) at similar daytime (9:00am). HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> or HIF-1&#x03B1;<sup>WT</sup>, TH-HIF-1&#x03B1;<sup>KO</sup> samples were collected and assayed in different days.</p></sec>
<sec id="s4n"><title>Tunel assay</title><p>Cell death was determined on CB sections using Click-iT&#x2122; TUNEL Alexa Fluor&#x2122; 488 Imaging Assay (ThermoFisher Scientific), following manufacture&#x2019;s indications. TUNEL<sup>&#x002B;</sup> cells across the whole CB parenchyma were counted and normalized by area.</p>
</sec>
<sec id="s4o">
<title>Plethysmography</title>
<p>Respiratory parameters were measured by unrestrained whole-body plethysmography (Data Sciences International, St. Paul, MN US). Mice were maintained in a hermetic chamber with controlled normoxic airflow (1.1 l/min) of 21&#x0025; O<sub>2</sub> (N<sub>2</sub> balanced, 5000ppm CO<sub>2</sub>, BOC Healthcare, Manchester, UK) until they were calm (30-40 minutes). Mice were then exposed to pre-mixed hypoxic air (1.1 l/min) of 10&#x0025; O<sub>2</sub> (N<sub>2</sub> balanced, 5000ppm CO<sub>2</sub>, BOC Healthcare) for 30 min (time-course experiments) or 10 min (VAH experiments). Real-time data were recorded and analyzed using Ponemah software (Data Sciences International). Each mouse was monitored throughout the experiment and periods of movements and/or grooming were noted and subsequently removed from the analysis. The transition periods between normoxia and hypoxia (2-3 min) were also removed from the analysis.</p>
</sec>
<sec id="s4p">
<title>Oxygen saturations</title>
<p>Oxygen saturations were measured using MouseOx Pulse Oximeter (Starr Life Sciences Corp, Oakmont, PA US) on anaesthetised (isofluorane) mice. Anaesthetic was vaporized with 2 l/min of 100&#x0025; O<sub>2</sub> gas flow (BOC Healthcare) and then shift to 2 l/min of pre-mixed 10&#x0025; O<sub>2</sub> flow (N<sub>2</sub> balanced, 5000ppm CO<sub>2</sub>, BOC Healthcare) for 5 min. Subsequently, gas flow was switched back to 100&#x0025; O<sub>2</sub>.</p>
</sec>
<sec id="s4q">
<title>Whole-body metabolic assessments</title>
<p>Energy expenditure was measured and recorded using the Columbus Instruments Oxymax system (Columbus, OH US) according to the manufacturer&#x2019;s instructions. Mice were randomly allocated to the chambers and they had free access to food and water throughout the experiment with the exception of fasting experiments. An initial 18-24h acclimation period was disregarded for all the experiments. Once mice were acclimated to the chamber, the composition of the influx gas was switched from 21&#x0025; O<sub>2</sub> to 10&#x0025; O<sub>2</sub> using a PEGAS mixer (Columbus Instruments). For maximum exertion testing, mice were allowed to acclimatize to the enclosed treadmill environment for 15 min before running. The treadmill was initiated at 5 meters/min and the mice warmed up for 5 minutes. The speed was increased up to 27 meters/min or exhaustion at 2.5 min intervals on a 15&#x00B0; incline. Exhaustion was defined as the third time the mouse refused to run for more than 3-5 seconds or when was unable to stay on the treadmill. Blood glucose and lactate levels were measured before and after exertion using a StatStrip Xpress (nova biomedical, Street-Waltham, MA US) glucose and lactate meters.</p>
</sec>
<sec id="s4r">
<title>Chronic hypoxia exposure and <italic>in vivo</italic> CB proliferation</title>
<p>Mice were exposed to a normobaric 10&#x0025; O<sub>2</sub> atmosphere in an enclosed chamber with controlled O<sub>2</sub> and CO<sub>2</sub> levels for up to 21 days. Humidity and CO<sub>2</sub> levels were quenched throughout the experiments by using silica gel (Sigma-Aldrich) and spherasorb soda lime (Intersurgical, Wokingham, UK), respectively. Haematocrit was measured in a bench-top haematocrit centrifuge. Haemoglobin levels were analyzed with a Vet abc analyzer (Horiba, Kyoto, Japan) according to the manufacture&#x2019;s instructions. Heart, spleen tissues were removed and their wet weights measured. Right ventricular systolic pressures were assessed using a pressure-volume loop system (Millar, Houston, TX US) as reported before (<xref rid="c8" ref-type="bibr">Cowburn et al., 2016</xref>). Mice were anaesthetized (isoflurane) and right-sided heart catheterization was performed through the right jugular vein. Lungs were processed for histology as describe above. Analogous procedures were followed for mice maintained in normoxia.</p>
<p>For hypoxia-induced <italic>in vivo</italic> CB proliferation studies, mice were injected intraperitoneally once a week with 50 mg/kg of BrdU (Sigma-Aldrich) and constantly supplied in their drinking water (1mg/ml) as previously shown (<xref rid="c40" ref-type="bibr">Pardal et al., 2007)</xref>. <italic>In vivo</italic> mTORC inhibition was achieved by intraperitoneal injection of rapamycin (6 mg kg<sup>-1</sup> day<sup>-1</sup>). Tissues were collected for histology after 14 days at 10&#x0025; O<sub>2</sub> as described above. VAH was recorded in vehicle control and rapamycin-injected C57BL/6J mice after 7 days in chronic hypoxia by plethysmography as explained above.</p>
</sec>
<sec id="s4s">
<title>Blood pressure measurement by radio-telemetry</title>
<p>All radio-telemetry hardware and software was purchased from Data Science International. Surgical implantation of radio-telemetry device was performed following University of Cambridge Animal Welfare and Ethical Review Body&#x2019;s (AWERB) recommendations and according to manufacturer&#x2019;s instructions. After surgery, mice were allowed to recover for at least 10 days. All baseline telemetry data were collected over a 72h period in a designated quiet room to ensure accurate and repeatable results. Blood pressure monitoring during hypoxia challenge was conducted in combination with Columbus Instruments Oxymax system and PEGAS mixer. Mice were placed in metabolic chambers and allowed to acclimate for 24h before the oxygen content of the flow gas was reduced to 10&#x0025;. Mice were kept for 48h at 10&#x0025; O<sub>2</sub> before being returned to normal atmospheric oxygen for a further 24h. For hypertension studies, mice were subsequently implanted with a micro osmotic pump (Alzet, Cupertino, CA; 1002 model) for Ang II (Sigma-Aldrich) infusion (490 ng min<sup>-1</sup> kg<sup>-1</sup>) for 2 weeks. Blood pressure, heart rate, temperature and activity were monitored for a 48h period after 7, 14 and 21 days after osmotic pump implantation.</p>
</sec>
<sec id="s4t">
<title>Glucose, insulin and lactate tolerant tests</title>
<p>All the blood glucose and lactate measurements were carried out with a StatStrip Xpress (nova biomedical) glucose and lactate meters. Blood was sampled from the tail vein. For glucose tolerance test (GTT), mice were placed in clean cages and fasted for 14-15 hours (overnight) with free access to water. Baseline glucose level (0 time point) was measured and then a glucose bolus (Sigma-Aldrich) of 2 g/kg in PBS was intraperitoneally injected. Glucose was monitored after 15, 30, 60, 90, 120 and 150 minutes. For insulin tolerance test, mice were fasted for 4 hours and baseline glucose was measured (0 time point). Next, insulin (Roche, <underline>Penzberg</underline>, Germany) was intraperitoneally injected (0.75 U/kg) and blood glucose content recorded after 15, 30, 60, 90 and 120 minutes. For lactate tolerance test, mice were injected with a bolus of 2 g/kg of sodium lactate (Sigma-Aldrich) in PBS and blood lactate measured after 15, 30, 60, 90 and 120 minutes.</p>
</sec>
<sec id="s4u">
<title>Statistical analysis</title>
<p>Particular statistic tests and sample size can be found in the figures and figure legends. Data are presented as the mean &#x00B1; standard error of the mean (SEM). Shapiro-Wilk normality test was used to determine Gaussian data distribution. Statistical significance between two groups was assessed by un-paired <italic>t</italic>-test in cases of normal distribution with a Welch&#x2019;s correction if standard deviations were different. In cases of non-normal distribution (or low sample size for normality test) the non-parametric Mann-Whitney U test was used. For multiple comparisons we used two-way ANOVA followed by Fisher&#x2019;s LSD test. Nonlinear regression (one-phase association) curve fitting, using a least squares method, was used to model the time course data in <xref rid="fig3" ref-type="fig">Figs. 3</xref>, <xref rid="fig5" ref-type="fig">5</xref> and Supplemental <xref rid="figS6a" ref-type="fig">Fig. S6</xref>. Extra sum-of-squares F test was used to compare fittings, and determine whether the data were best represented by a single curve, or by separate ones. Individual area under the curve (AUC) was calculated for the circadian time-courses in <xref rid="fig3" ref-type="fig">Figs. 3</xref>, <xref rid="fig5" ref-type="fig">5</xref>; Supplemental <xref rid="figS6a" ref-type="fig">Figs. S6</xref>, S7, followed by un-paired t-test or non-parametric Mann-Whitney U test as explained above. Statistical significance was considered if p &#x2264; 0.05. Analysis was carried out using Prism6.0f (GraphPad software, La Jolla, CA US) for Mac OS X.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Ackowledgements</title>
<p>This work is funded by the Wellcome Trust (grant WT092738MA).</p>
</ack>
<sec id="s5" sec-type="COI-statement">
<title>Competing interests</title>
<p>No competing interest declared.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>Conceptualization, D.M. and R.S.J.; Investigation, D.M., A.C., H.T.T., and P.O.S.; Writing-Original Draft, D.M. and R.S.J.; Writing-Review &#x0026; Editing, D.M., A.C., H.T.T., P.O.S., J.L.B., and R.S.J.; Supervision, D.M., J.L.B. and R.S.J.; Funding Acquisition, R.S.J.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Annese</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Navarro-Guerrero</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Rodriguez-Prieto</surname>, <given-names>I.</given-names></string-name>, &#x0026; <string-name><surname>Pardal</surname>, <given-names>R.</given-names></string-name> (<year>2017</year>). <article-title>Physiological Plasticity of Neural-Crest-Derived Stem Cells in the Adult Mammalian Carotid Body</article-title>. <source>Cell Rep</source>, <volume>19</volume>(<issue>3</issue>), <fpage>471</fpage>&#x2013;<lpage>478</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.065</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Arias-Stella</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Valcarcel</surname>, <given-names>J.</given-names></string-name> (<year>1976</year>). <article-title>Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance</article-title>. <source>Hum Pathol</source>, <volume>7</volume>(<issue>4</issue>), <fpage>361</fpage>&#x2013;<lpage>373</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Brugarolas</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lei</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hurley</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Manning</surname>, <given-names>B. D.</given-names></string-name>, <string-name><surname>Reiling</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Hafen</surname>, <given-names>E.</given-names></string-name>, &#x2026; <string-name><surname>Kaelin</surname>, <given-names>W. G.</given-names>, <suffix>Jr.</suffix></string-name> (<year>2004</year>). <article-title>Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex</article-title>. <source>Genes Dev</source>, <volume>18</volume>(<issue>23</issue>), <fpage>2893</fpage>&#x2013;<lpage>2904</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.1256804</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Brusselmans</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Compernolle</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Tjwa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wiesener</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Maxwell</surname>, <given-names>P. H.</given-names></string-name>, <string-name><surname>Collen</surname>, <given-names>D.</given-names></string-name>, &#x0026; <string-name><surname>Carmeliet</surname>, <given-names>P.</given-names></string-name> (<year>2003</year>). <article-title>Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia</article-title>. <source>J Clin Invest</source>, <volume>111</volume>(<issue>10</issue>), <fpage>1519</fpage>&#x2013;<lpage>1527</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI15496</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Bryant</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Carrick</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>McConaha</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>B. R.</given-names></string-name>, <string-name><surname>Shay</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Moore</surname>, <given-names>C. S.</given-names></string-name>, &#x2026; <string-name><surname>Lawson</surname>, <given-names>W. E.</given-names></string-name> (<year>2016</year>). <article-title>Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>, <volume>310</volume>(<issue>3</issue>), <fpage>L249</fpage>&#x2013;<lpage>262</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.00258.2015</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Carmeliet</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Dor</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Herbert</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Fukumura</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Brusselmans</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dewerchin</surname>, <given-names>M.</given-names></string-name>, &#x2026; <string-name><surname>Keshert</surname>, <given-names>E.</given-names></string-name> (<year>1998</year>). <article-title>Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis</article-title>. <source>Nature</source>, <volume>394</volume>(<issue>6692</issue>), <fpage>485</fpage>&#x2013;<lpage>490</lpage>. doi: <pub-id pub-id-type="doi">10.1038/28867</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Compernolle</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Brusselmans</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Acker</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hoet</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Tjwa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Beck</surname>, <given-names>H.</given-names></string-name>, &#x2026; <string-name><surname>Carmeliet</surname>, <given-names>P.</given-names></string-name> (<year>2002</year>). <article-title>Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice</article-title>. <source>Nat Med</source>, <volume>8</volume>(<issue>7</issue>), <fpage>702</fpage>&#x2013;<lpage>710</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm721</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Cowburn</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Crosby</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Macias</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Branco</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Colaco</surname>, <given-names>R. D.</given-names></string-name>, <string-name><surname>Southwood</surname>, <given-names>M.</given-names></string-name>, &#x2026; <string-name><surname>Johnson</surname>, <given-names>R. S.</given-names></string-name> (<year>2016</year>). <article-title>HIF2alpha-arginase axis is essential for the development of pulmonary hypertension</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>113</volume>(<issue>31</issue>), <fpage>8801</fpage>&#x2013;<lpage>8806</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1602978113</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation><string-name><surname>Cowburn</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Macias</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Summers</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chilvers</surname>, <given-names>E. R.</given-names></string-name>, &#x0026; <string-name><surname>Johnson</surname>, <given-names>R. S.</given-names></string-name> (<year>2017</year>). Cardiovascular adaptation to hypoxia and the role of peripheral resistance. Elife, 6. doi: <pub-id pub-id-type="doi">10.7554/eLife.28755</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Du</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tong</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, &#x0026; <string-name><surname>Yan</surname>, <given-names>Z.</given-names></string-name> (<year>2016</year>). <article-title>The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas</article-title>. <source>Int J Endocrinol</source>, <volume>2016</volume>, <fpage>5286972</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/5286972</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Elorza</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Soro-Arnaiz</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Melendez-Rodriguez</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Rodriguez-Vaello</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Marsboom</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>de Carcer</surname>, <given-names>G.</given-names></string-name>, &#x2026; <string-name><surname>Aragones</surname>, <given-names>J.</given-names></string-name> (<year>2012</year>). <article-title>HIF2alpha acts as an mTORC1 activator through the amino acid carrier SLC7A5</article-title>. <source>Mol Cell</source>, <volume>48</volume>(<issue>5</issue>), <fpage>681</fpage>&#x2013;<lpage>691</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2012.09.017</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Favier</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Amar</surname>, <given-names>L.</given-names></string-name>, &#x0026; <string-name><surname>Gimenez-Roqueplo</surname>, <given-names>A. P.</given-names></string-name> (<year>2015</year>). <article-title>Paraganglioma and phaeochromocytoma: from genetics to personalized medicine</article-title>. <source>Nat Rev Endocrinol</source>, <volume>11</volume>(<issue>2</issue>), <fpage>101</fpage>&#x2013;<lpage>111</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrendo.2014.188</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Gao</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bonilla-Henao</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Garcia-Flores</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Arias-Mayenco</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ortega-Saenz</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name> (<year>2017</year>). <article-title>Gene expression analyses reveal metabolic specifications in acute O2-sensing chemoreceptor cells</article-title>. <source>J Physiol</source>, <volume>595</volume>(<issue>18</issue>), <fpage>6091</fpage>&#x2013;<lpage>6120</lpage>. doi: <pub-id pub-id-type="doi">10.1113/JP274684</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Goda</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ryan</surname>, <given-names>H. E.</given-names></string-name>, <string-name><surname>Khadivi</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>McNulty</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Rickert</surname>, <given-names>R. C.</given-names></string-name>, &#x0026; <string-name><surname>Johnson</surname>, <given-names>R. S.</given-names></string-name> (<year>2003</year>). <article-title>Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia</article-title>. <source>Mol Cell Biol</source>, <volume>23</volume>(<issue>1</issue>), <fpage>359</fpage>&#x2013;<lpage>369</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Gruber</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Keith</surname>, <given-names>B.</given-names></string-name>, &#x0026; <string-name><surname>Simon</surname>, <given-names>M. C.</given-names></string-name> (<year>2007</year>). <article-title>Acute postnatal ablation of Hif-2alpha results in anemia</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>104</volume>(<issue>7</issue>), <fpage>2301</fpage>&#x2013;<lpage>2306</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0608382104</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Heath</surname>, <given-names>D.</given-names></string-name>, &#x0026; <string-name><surname>Edwards</surname>, <given-names>C.</given-names></string-name> (<year>1971</year>). <article-title>The carotid body in cardiopulmonary disease</article-title>. <source>Geriatrics</source>, <volume>26</volume>(<issue>12</issue>), <fpage>110</fpage>&#x2013;<lpage>111</lpage> passim.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Heath</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Jago</surname>, <given-names>R.</given-names></string-name> (<year>1982</year>). <article-title>Hyperplasia of the carotid body</article-title>. <source>J Pathol</source>, <volume>138</volume>(<issue>2</issue>), <fpage>115</fpage>&#x2013;<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1002/path.1711380203</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Hodson</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Nicholls</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Turner</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Llyr</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Fielding</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Douglas</surname>, <given-names>G.</given-names></string-name>, &#x2026; <string-name><surname>Bishop</surname>, <given-names>T.</given-names></string-name> (<year>2016</year>). <article-title>Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway</article-title>. <source>J Physiol</source>, <volume>594</volume>(<issue>5</issue>), <fpage>1179</fpage>&#x2013;<lpage>1195</lpage>. doi: <pub-id pub-id-type="doi">10.1113/JP271050</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Hubbi</surname>, <given-names>M. E.</given-names></string-name>, &#x0026; <string-name><surname>Semenza</surname>, <given-names>G. L.</given-names></string-name> (<year>2015</year>). <article-title>Regulation of cell proliferation by hypoxia-inducible factors</article-title>. <source>Am J Physiol Cell Physiol</source>, <volume>309</volume>(<issue>12</issue>), <fpage>C775</fpage>&#x2013;<lpage>782</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpcell.00279.2015</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Iturriaga</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Del Rio</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Idiaquez</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Somers</surname>, <given-names>V. K.</given-names></string-name> (<year>2016</year>). <article-title>Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease</article-title>. <source>Biol Res</source>, <volume>49</volume>, <fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40659-016-0073-8</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Iyer</surname>, <given-names>N. V.</given-names></string-name>, <string-name><surname>Kotch</surname>, <given-names>L. E.</given-names></string-name>, <string-name><surname>Agani</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Leung</surname>, <given-names>S. W.</given-names></string-name>, <string-name><surname>Laughner</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wenger</surname>, <given-names>R. H.</given-names></string-name>, &#x2026; <string-name><surname>Semenza</surname>, <given-names>G. L.</given-names></string-name> (<year>1998</year>). <article-title>Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha</article-title>. <source>Genes Dev</source>, <volume>12</volume>(<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>162</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation><string-name><surname>Kameda</surname>, <given-names>Y.</given-names></string-name> (<year>2005</year>). <article-title>Mash1 is required for glomus cell formation in the mouse carotid body</article-title>. <source>Dev Biol</source>, <volume>283</volume>(<issue>1</issue>), <fpage>128</fpage>&#x2013;<lpage>139</lpage>.doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2005.04.004</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Kameda</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ito</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nishimaki</surname>, <given-names>T.</given-names></string-name>, &#x0026; <string-name><surname>Gotoh</surname>, <given-names>N.</given-names></string-name> (<year>2008</year>). <article-title>FRS2 alpha 2F/2F mice lack carotid body and exhibit abnormalities of the superior cervical sympathetic ganglion and carotid sinus nerve</article-title>. <source>Dev Biol</source>, <volume>314</volume>(<issue>1</issue>), <fpage>236</fpage>&#x2013;<lpage>247</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ydbio.2007.12.002</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Kapitsinou</surname>, <given-names>P. P.</given-names></string-name>, <string-name><surname>Rajendran</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Astleford</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Michael</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schonfeld</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>Fields</surname>, <given-names>T.</given-names></string-name>, &#x2026; <string-name><surname>Haase</surname>, <given-names>V. H.</given-names></string-name> (<year>2016</year>). <article-title>The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice</article-title>. <source>Mol Cell Biol</source>, <volume>36</volume>(<issue>10</issue>), <fpage>1584</fpage>&#x2013;<lpage>1594</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.01055-15</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Kline</surname>, <given-names>D. D.</given-names></string-name>, <string-name><surname>Peng</surname>, <given-names>Y. J.</given-names></string-name>, <string-name><surname>Manalo</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Semenza</surname>, <given-names>G. L.</given-names></string-name>, &#x0026; <string-name><surname>Prabhakar</surname>, <given-names>N. R.</given-names></string-name> (<year>2002</year>). <article-title>Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>99</volume>(<issue>2</issue>), <fpage>821</fpage>&#x2013;<lpage>826</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.022634199</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Koshiji</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kageyama</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Pete</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Horikawa</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Barrett</surname>, <given-names>J. C.</given-names></string-name>, &#x0026; <string-name><surname>Huang</surname>, <given-names>L. E.</given-names></string-name> (<year>2004</year>). <article-title>HIF-1alpha induces cell cycle arrest by functionally counteracting Myc</article-title>. <source>EMBO J</source>, <volume>23</volume>(<issue>9</issue>), <fpage>1949</fpage>&#x2013;<lpage>1956</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.emboj.7600196</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Laplante</surname>, <given-names>M.</given-names></string-name>, &#x0026; <string-name><surname>Sabatini</surname>, <given-names>D. M.</given-names></string-name> (<year>2012</year>). <article-title>mTOR signaling in growth control and disease</article-title>. <source>Cell</source>, <volume>149</volume>(<issue>2</issue>), <fpage>274</fpage>&#x2013;<lpage>293</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2012.03.017</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Le Douarin</surname>, <given-names>N. M.</given-names></string-name> (<year>1986</year>). <article-title>Cell line segregation during peripheral nervous system ontogeny</article-title>. <source>Science</source>, <volume>231</volume>(<issue>4745</issue>), <fpage>1515</fpage>&#x2013;<lpage>1522</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Lindeberg</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Usoskin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bengtsson</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gustafsson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kylberg</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Soderstrom</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Ebendal</surname>, <given-names>T.</given-names></string-name> (<year>2004</year>). <article-title>Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus</article-title>. <source>Genesis</source>, <volume>40</volume>(<issue>2</issue>), <fpage>67</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gene.20065</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation><string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Cash</surname>, <given-names>T. P.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>R. G.</given-names></string-name>, <string-name><surname>Keith</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>C. B.</given-names></string-name>, &#x0026; <string-name><surname>Simon</surname>, <given-names>M. C.</given-names></string-name> (<year>2006</year>). <article-title>Hypoxia-induced energy stress regulates mRNA translation and cell growth</article-title>. <source>Mol Cell</source>, <volume>21</volume>(<issue>4</issue>), <fpage>521</fpage>&#x2013;<lpage>531</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2006.01.010</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Macias</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Platero-Luengo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ortega-Saenz</surname>, <given-names>P.</given-names></string-name>, &#x0026; <string-name><surname>Pardal</surname>, <given-names>R.</given-names></string-name> (<year>2016</year>). <article-title>Carotid body oxygen sensing and adaptation to hypoxia</article-title>. <source>Pflugers Arch</source>, <volume>468</volume>(<issue>1</issue>), <fpage>59</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00424-015-1734-0</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation><string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ortega-Saenz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gonzalez-Rodriguez</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Fernandez-Aguera</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Macias</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pardal</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Gao</surname>, <given-names>L.</given-names></string-name> (<year>2016</year>). <article-title>Oxygen-sensing by arterial chemoreceptors: Mechanisms and medical translation</article-title>. <source>Mol Aspects Med</source>, <volume>47-48</volume>, <fpage>90</fpage>&#x2013;<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mam.2015.12.002</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Lorenzo</surname>, <given-names>F. R.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ng Tang Fui</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Vankayalapati</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhuang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Huynh</surname>, <given-names>T.</given-names></string-name>, &#x2026; <string-name><surname>Prchal</surname>, <given-names>J. T.</given-names></string-name> (<year>2013</year>). <article-title>A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma</article-title>. <source>J Mol Med (Berl)</source>, <volume>91</volume>(<issue>4</issue>), <fpage>507</fpage>&#x2013;<lpage>512</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00109-012-0967-z</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Ma</surname>, <given-names>X. M.</given-names></string-name>, &#x0026; <string-name><surname>Blenis</surname>, <given-names>J.</given-names></string-name> (<year>2009</year>). <article-title>Molecular mechanisms of mTOR-mediated translational control</article-title>. <source>Nat Rev Mol Cell Biol</source>, <volume>10</volume>(<issue>5</issue>), <fpage>307</fpage>&#x2013;<lpage>318</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm2672</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Macias</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Fernandez-Aguera</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Bonilla-Henao</surname>, <given-names>V.</given-names></string-name>, &#x0026; <string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name> (<year>2014</year>). <article-title>Deletion of the von Hippel-Lindau gene causes sympathoadrenal cell death and impairs chemoreceptor-mediated adaptation to hypoxia</article-title>. <source>EMBO Mol Med</source>, <volume>6</volume>(<issue>12</issue>), <fpage>1577</fpage>&#x2013;<lpage>1592</lpage>. doi: <pub-id pub-id-type="doi">10.15252/emmm.201404153</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Madden</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Vadula</surname>, <given-names>M. S.</given-names></string-name>, &#x0026; <string-name><surname>Kurup</surname>, <given-names>V. P.</given-names></string-name> (<year>1992</year>). <article-title>Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells</article-title>. <source>Am J Physiol</source>, <volume>263</volume>(<issue>3 Pt 1</issue>), <fpage>L384</fpage>&#x2013;<lpage>393</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Madisen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zwingman</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Sunkin</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Oh</surname>, <given-names>S. W.</given-names></string-name>, <string-name><surname>Zariwala</surname>, <given-names>H. A.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>H.</given-names></string-name>, &#x2026; <string-name><surname>Zeng</surname>, <given-names>H.</given-names></string-name> (<year>2010</year>). <article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title>. <source>Nat Neurosci</source>, <volume>13</volume>(<issue>1</issue>), <fpage>133</fpage>&#x2013;<lpage>140</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.2467</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>McBryde</surname>, <given-names>F. D.</given-names></string-name>, <string-name><surname>Abdala</surname>, <given-names>A. P.</given-names></string-name>, <string-name><surname>Hendy</surname>, <given-names>E. B.</given-names></string-name>, <string-name><surname>Pijacka</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Marvar</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Moraes</surname>, <given-names>D. J.</given-names></string-name>, &#x2026; <string-name><surname>Paton</surname>, <given-names>J. F.</given-names></string-name> (<year>2013</year>). <article-title>The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension</article-title>. <source>Nat Commun</source>, <volume>4</volume>, <fpage>2395</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms3395</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Ortega-Saenz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Pascual</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Piruat</surname>, <given-names>J. I.</given-names></string-name>, &#x0026; <string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name> (<year>2007</year>). <article-title>Mechanisms of acute oxygen sensing by the carotid body: lessons from genetically modified animals</article-title>. <source>Respir Physiol Neurobiol</source>, <volume>157</volume>(<issue>1</issue>), <fpage>140</fpage>&#x2013;<lpage>147</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.resp.2007.02.009</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Pardal</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ortega-Saenz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Duran</surname>, <given-names>R.</given-names></string-name>, &#x0026; <string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name> (<year>2007</year>). <article-title>Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body</article-title>. <source>Cell</source>, <volume>131</volume>(<issue>2</issue>), <fpage>364</fpage>&#x2013;<lpage>377</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2007.07.043</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Pearse</surname>, <given-names>A. G.</given-names></string-name>, <string-name><surname>Polak</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Rost</surname>, <given-names>F. W.</given-names></string-name>, <string-name><surname>Fontaine</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Le Lievre</surname>, <given-names>C.</given-names></string-name>, &#x0026; <string-name><surname>Le Douarin</surname>, <given-names>N.</given-names></string-name> (<year>1973</year>). <article-title>Demonstration of the neural crest origin of type I (APUD) cells in the avian carotid body, using a cytochemical marker system</article-title>. <source>Histochemie</source>, <volume>34</volume>(<issue>3</issue>), <fpage>191</fpage>&#x2013;<lpage>203</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Peng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Drysdale</surname>, <given-names>L.</given-names></string-name>, &#x0026; <string-name><surname>Fong</surname>, <given-names>G. H.</given-names></string-name> (<year>2000</year>). <article-title>The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>97</volume>(<issue>15</issue>), <fpage>8386</fpage>&#x2013;<lpage>8391</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.140087397</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Peng</surname>, <given-names>Y. J.</given-names></string-name>, <string-name><surname>Nanduri</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Khan</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kinsman</surname>, <given-names>B.</given-names></string-name>, &#x2026; <string-name><surname>Prabhakar</surname>, <given-names>N. R.</given-names></string-name> (<year>2011</year>). <article-title>Hypoxia-inducible factor 2alpha (HIF-2alpha) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>108</volume>(<issue>7</issue>), <fpage>3065</fpage>&#x2013;<lpage>3070</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1100064108</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Peng</surname>, <given-names>Y. J.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Ramakrishnan</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Bosch-Marce</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>G. K.</given-names></string-name>, <string-name><surname>Prabhakar</surname>, <given-names>N. R.</given-names></string-name> (<year>2006</year>). <article-title>Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia</article-title>. <source>J Physiol</source>, <volume>577</volume>(Pt <issue>2</issue>), <fpage>705</fpage>&#x2013;<lpage>716</lpage>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2006.114033</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Pijacka</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Moraes</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Ratcliffe</surname>, <given-names>L. E.</given-names></string-name>, <string-name><surname>Nightingale</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Hart</surname>, <given-names>E. C.</given-names></string-name>, <string-name><surname>da Silva</surname>, <given-names>M. P.</given-names></string-name>, &#x2026; <string-name><surname>Paton</surname>, <given-names>J. F.</given-names></string-name>. (<year>2016</year>). <article-title>Purinergic receptors in the carotid body as a new drug target for controlling hypertension</article-title>. <source>Nat Med</source>, <volume>22</volume>(<issue>10</issue>), <fpage>1151</fpage>&#x2013;<lpage>1159</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm.4173</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Platero-Luengo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gonzalez-Granero</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Duran</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Diaz-Castro</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Piruat</surname>, <given-names>J. I.</given-names></string-name>, <string-name><surname>Garcia-Verdugo</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Lopez-Barneo</surname>, <given-names>J.</given-names></string-name> (<year>2014</year>). <article-title>An O2-sensitive glomus cell-stem cell synapse induces carotid body growth in chronic hypoxia</article-title>. <source>Cell</source>, <volume>156</volume>(<issue>1&#x2013;2</issue>), <fpage>291</fpage>&#x2013;<lpage>303</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2013.12.013</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>, <given-names>H. E.</given-names></string-name>, <string-name><surname>Lo</surname>, <given-names>J.</given-names></string-name>, &#x0026; <string-name><surname>Johnson</surname>, <given-names>R. S.</given-names></string-name> (<year>1998</year>). <article-title>HIF-1 alpha is required for solid tumor formation and embryonic vascularization</article-title>. <source>EMBO J</source>, <volume>17</volume>(<issue>11</issue>), <fpage>3005</fpage>&#x2013;<lpage>3015</lpage>. doi: <pub-id pub-id-type="doi">10.1093/emboj/17.11.3005</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Saldana</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Salem</surname>, <given-names>L. E.</given-names></string-name>, &#x0026; <string-name><surname>Travezan</surname>, <given-names>R.</given-names></string-name> (<year>1973</year>). <article-title>High altitude hypoxia and chemodectomas</article-title>. <source>Hum Pathol</source>, <volume>4</volume>(<issue>2</issue>), <fpage>251</fpage>&#x2013;<lpage>263</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Schindelin</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Arganda-Carreras</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Frise</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kaynig</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Longair</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pietzsch</surname>, <given-names>T.</given-names></string-name>, &#x2026; <string-name><surname>Cardona</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>). <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nat Methods</source>, <volume>9</volume>(<issue>7</issue>), <fpage>676</fpage>&#x2013;<lpage>682</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Schnell</surname>, <given-names>P. O.</given-names></string-name>, <string-name><surname>Ignacak</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Bauer</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Striet</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Paulding</surname>, <given-names>W. R.</given-names></string-name>, &#x0026; <string-name><surname>Czyzyk-Krzeska</surname>, <given-names>M. F.</given-names></string-name> (<year>2003</year>). <article-title>Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors</article-title>. <source>J Neurochem</source>, <volume>85</volume>(<issue>2</issue>), <fpage>483</fpage>&#x2013;<lpage>491</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Scortegagna</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ding</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Oktay</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Gaur</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Thurmond</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>L. J.</given-names></string-name>, &#x2026; <string-name><surname>Garcia</surname>, <given-names>J. A.</given-names></string-name> (<year>2003</year>). <article-title>Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice</article-title>. <source>Nat Genet</source>, <volume>35</volume>(<issue>4</issue>), <fpage>331</fpage>&#x2013;<lpage>340</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng1266</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Slingo</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Turner</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Christian</surname>, <given-names>H. C.</given-names></string-name>, <string-name><surname>Buckler</surname>, <given-names>K. J.</given-names></string-name>, &#x0026; <string-name><surname>Robbins</surname>, <given-names>P. A.</given-names></string-name> (<year>2014</year>). <article-title>The von Hippel-Lindau Chuvash mutation in mice causes carotid-body hyperplasia and enhanced ventilatory sensitivity to hypoxia</article-title>. <source>J Appl Physiol</source> (1985), <volume>116</volume>(<issue>7</issue>), <fpage>885</fpage>&#x2013;<lpage>892</lpage>. doi: <pub-id pub-id-type="doi">10.1152/japplphysiol.00530.2013</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation><string-name><surname>Stenmark</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Meyrick</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Galie</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Mooi</surname>, <given-names>W. J.</given-names></string-name>, &#x0026; <string-name><surname>McMurtry</surname>, <given-names>I. F.</given-names></string-name> (<year>2009</year>).<article-title>Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>, <volume>297</volume>(<issue>6</issue>), <fpage>L1013</fpage>&#x2013;<lpage>1032</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.00217.2009</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Tan</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Kerestes</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Percy</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Pietrofesa</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Khurana</surname>, <given-names>T. S.</given-names></string-name>, &#x2026; <string-name><surname>Lee</surname>, <given-names>F. S.</given-names></string-name> (<year>2013</year>). <article-title>Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation</article-title>. <source>J Biol Chem</source>, <volume>288</volume>(<issue>24</issue>), <fpage>17134</fpage>&#x2013;<lpage>17144</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M112.444059</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Teppema</surname>, <given-names>L. J.</given-names></string-name>, &#x0026; <string-name><surname>Dahan</surname>, <given-names>A.</given-names></string-name> (<year>2010</year>). <article-title>The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis</article-title>. <source>Physiol Rev</source>, <volume>90</volume>(<issue>2</issue>), <fpage>675</fpage>&#x2013;<lpage>754</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00012.2009</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Tian</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hammer</surname>, <given-names>R. E.</given-names></string-name>, <string-name><surname>Matsumoto</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Russell</surname>, <given-names>D. W.</given-names></string-name>, &#x0026; <string-name><surname>McKnight</surname>, <given-names>S. L.</given-names></string-name> (<year>1998</year>). <article-title>The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development</article-title>. <source>Genes Dev</source>, <volume>12</volume>(<issue>21</issue>), <fpage>3320</fpage>&#x2013;<lpage>3324</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Torres-Capelli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Marsboom</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Q. O.</given-names></string-name>, <string-name><surname>Tello</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rodriguez</surname>, <given-names>F. M.</given-names></string-name>, <string-name><surname>Alonso</surname>, <given-names>T.</given-names></string-name>, &#x2026; <string-name><surname>Aragones</surname>, <given-names>J.</given-names></string-name> (<year>2016</year>). <article-title>Role Of Hif2alpha Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation</article-title>. <source>Sci Rep</source>, <volume>6</volume>, <fpage>25357</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep25357</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>Z. Y.</given-names></string-name>, &#x0026; <string-name><surname>Bisgard</surname>, <given-names>G. E.</given-names></string-name> (<year>2002</year>). <article-title>Chronic hypoxia-induced morphological and neurochemical changes in the carotid body</article-title>. <source>Microsc Res Tech</source>, <volume>59</volume>(<issue>3</issue>), <fpage>168</fpage>&#x2013;<lpage>177</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jemt.10191</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Chien</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Kaleem</surname>, <given-names>S.</given-names></string-name>, &#x0026; <string-name><surname>Matsunami</surname>, <given-names>H.</given-names></string-name> (<year>2016</year>). <article-title>Single cell transcriptome analysis of mouse carotid body glomus cells</article-title>. <source>J Physiol</source>, <volume>594</volume>(<issue>15</issue>), <fpage>4225</fpage>&#x2013;<lpage>4251</lpage>. doi: <pub-id pub-id-type="doi">10.1113/JP271936</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Zhuang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Lorenzo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Merino</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fojo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kebebew</surname>, <given-names>E.</given-names></string-name>, &#x2026; <string-name><surname>Pacak</surname>, <given-names>K.</given-names></string-name> (<year>2012</year>). <article-title>Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia</article-title>. <source>N Engl J Med</source>, <volume>367</volume>(<issue>10</issue>), <fpage>922</fpage>&#x2013;<lpage>930</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1205119</pub-id></mixed-citation></ref>
</ref-list>
<sec sec-type="supplementary-material">
<title>Figures</title>
<fig id="figS1a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1-figure supplement 1.</label>
<caption>
<p>Sympathoadrenal gene deletion by TH-IRES-Cre mouse strain. (A) TH-Cre-mediated recombination in carotid bifurcation (left panels) and adrenal gland (right panels) sections dissected from the TH-Td-tomato reporter mice (Cre&#x002B;) compared to Td-Tomato (Cre-) mice. Notice the presence of Td-tomato fluorescence into the CB glomus cells, SCG sympathetic neurons and adrenal medulla due to TH-Cre activity (lower panels). Dashed lines delineate the location of SCG and AM within Td-tomato (Cre-) sections. SCG, superior cervical ganglion; CB, carotid body; AM, adrenal medulla. Scale bars: 100 &#x03BC;m for carotid bifurcation and 200 &#x03BC;m for adrenal gland sections. (B-C) Relative <italic>Hif-2&#x03B1;</italic> (B) and <italic>Hif-1&#x03B1;</italic> (C) gene deletion of dissected SCG (left graphs) and AM (right graphs) from TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 4) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue, n = 4) compared to their respective littermate controls (HIF-2&#x03B1;<sup>WT</sup>, n = 4; HIF-1&#x03B1;<sup>WT</sup>, n = 2). Data are expressed as mean &#x00B1;SEM. Unpaired t-test, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001.</p>
</caption>
<graphic xlink:href="250928_figS1a.tif"/>
</fig>
<fig id="figS3a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3-figure supplement 1.</label>
<caption>
<p>Secretory and electrophysiological properties in AM and SCG from TH-HIF-2&#x03B1;<sup>KO</sup> mice. (A and B) Representative amperometric recordings of catecholamine release by chromaffin cells from HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> mice (8-12 weeks old) in response to low PO<sub>2</sub> (PO<sub>2</sub> &#x2248; 10-15 mmHg), hypercapnia (20&#x0025; CO<sub>2</sub>) and 20 mM KCl. (C) Percentage of AM slices with response to hypoxia, 20&#x0025; CO<sub>2</sub> and 20 mM KCl, respectively. HIF-2&#x03B1;<sup>WT</sup> n = 8; TH-HIF-2&#x03B1;<sup>KO</sup>, n = 7. (D) Averaged secretion rate of chromaffin cells from HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> mice exposed to hypoxia(PO<sub>2</sub> &#x2248; 10-15 mmHg), hypercapnia (20&#x0025; CO<sub>2</sub>) and 20 mM KCl. Each data point represents the mean of 2-3 recordings per mouse. HIF-2&#x03B1;<sup>WT</sup>, n = 8; TH-HIF-2&#x03B1;<sup>KO</sup>, n = 7. Data are expressed as mean &#x00B1;SEM. One-way ANOVA, non-significant. (E and F) Ca<sup>2&#x002B;</sup> and K<sup>&#x002B;</sup> current/voltage (I/V) curves of AM chromaffin cells (E) and SCG sympathetic neurons (F) dissociated from HIF-2&#x03B1;<sup>WT</sup> (n = 9 cells from 3 mice) and TH-HIF-2&#x03B1;<sup>KO</sup> (n = 10 cells from 3 mice) mice. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_figS3a.tif"/>
</fig>
<fig id="figS3b" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3-figure supplement 2.</label>
<caption>
<p>Respiratory parameters of TH-HIF-2&#x03B1;<sup>KO</sup> and TH-HIF-1&#x03B1;<sup>KO</sup> mice exposed to acute hypoxia. (A-J) Averaged tidal volume (A and F), inspiration time (B and G), expiration time (C and H), peak inspiratory flow (D and I) and peak expiratory flow (E and J) of TH-HIF-2&#x03B1;<sup>KO</sup> (n = 4) and TH-HIF-1&#x03B1;<sup>KO</sup> (n = 3) respect to control mice (HIF-2&#x03B1;<sup>WT</sup>, n = 4; HIF-1&#x03B1;<sup>WT</sup>, n = 3) before and during the first 5 minutes breathing 10&#x0025; O<sub>2.</sub> Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001.</p>
</caption>
<graphic xlink:href="250928_figS3b.tif"/>
</fig>
<fig id="figS4a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4-figure supplement 1.</label>
<caption>
<p>Impaired hypoxia-induced CB proliferation in TH-HIF-2&#x03B1;<sup>KO</sup> mice. (A) Glial fibrillary acidic protein (GFAP) immunostaining to illustrate the presence of CB stem cells in carotid bifurcation of both HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup>mice.Scale bars: 50 &#x00B5;m.(B)DoubleTH<sup>&#x002B;</sup>BrdU<sup>&#x002B;</sup> immunofluorescence performed on carotid bifurcation sections from HIF-2&#x03B1;<sup>WT</sup> (top) and TH-HIF-2&#x03B1;<sup>KO</sup> (bottom) mice exposed to 10&#x0025; O<sub>2</sub> for 14 days. Dashed rectangles are shown at higher magnification on the right panels. Newly formed TH<sup>&#x002B;</sup> cells are indicated with white arrows. Scale bars: 200 &#x03BC;m (left pictures), 50 &#x03BC;m (right pictures). (C and D) Quantification of total CB volume (C, n = 4 per genotype and condition) and double BrdU<sup>&#x002B;</sup> TH<sup>&#x002B;</sup> cells number (D, n = 3 per genotype and condition) in HIF-2&#x03B1;<sup>WT</sup> (black) and TH-HIF-2&#x03B1;<sup>KO</sup> (red) mice maintained for 14 days in hypoxia (10&#x0025; O<sub>2</sub>). Data are presented as mean &#x00B1;SEM. Unpaired t-test, &#x002A;&#x002A;p &#x003C; 0.01, &#x002A;&#x002A;&#x002A;p &#x003C; 0.001.</p>
</caption>
<graphic xlink:href="250928_figS4a.tif"/>
</fig>
<fig id="figS4b" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4-figure supplement 2.</label>
<caption>
<p>Adaptation to hypoxia in TH-HIF-1&#x03B1;<sup>KO</sup> animals. (A) Haematocrit levels of HIF-1&#x03B1;<sup>WT</sup> (black, 21&#x0025; O<sub>2</sub>, n = 4; 10&#x0025; O2, n = 8) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue, 21&#x0025; O<sub>2</sub>, n = 4; 10&#x0025; O2, n = 8) mice housed at 21&#x0025; O<sub>2</sub> or after 21 days at 10&#x0025; O<sub>2</sub>. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.001, ns, non-significant. (B and C) Normalized heart (B) and spleen (C) weight of HIF-1&#x03B1;<sup>WT</sup> (black) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue) mice before and after 21 days of hypoxia (10&#x0025; O<sub>2</sub>) exposure. In B, HIF-1&#x03B1;<sup>WT</sup>, 21&#x0025; O<sub>2</sub>, n = 9; 10&#x0025; O<sub>2</sub>, n = 8; TH-HIF-1&#x03B1;<sup>KO</sup>, n = 9, per condition. In C, 21&#x0025; O<sub>2</sub>, n = 4 per genotype; 10&#x0025; O2, n = 5 per genotype. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;p &#x003C; 0.05, ns, non-significant. (D) Fulton index on hearts dissected from HIF-1&#x03B1;<sup>WT</sup> (black) and TH-HIF-1&#x03B1;<sup>KO</sup> (blue) mice before and after 21 days in hypoxia (10&#x0025; O<sub>2</sub>). HIF-1&#x03B1;<sup>WT</sup>, 21&#x0025; O<sub>2</sub>, n = 7; 10&#x0025; O<sub>2</sub>, n = 8; TH-HIF-1&#x03B1;<sup>KO</sup>, n = 8, per condition. Data are expressed as mean &#x00B1;SEM. Two-way ANOVA, &#x002A;&#x002A;&#x002A;&#x002A;p &#x003C; 0.0001, ns, non-significant. RV, right ventricle. LV, left ventricle.</p>
</caption>
<graphic xlink:href="250928_figS4b.tif"/>
</fig>
<fig id="figS5a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5-figure supplement 1.</label>
<caption>
<p>Cardiovascular homeostasis in response to hypoxia and Ang II-induced experimental hypertension. (A and B) Circadian oscillations in subcutaneous temperature (A) and physical activity (B) of radiotelemetry-implanted HIF-2&#x03B1;<sup>WT</sup> (black, n = 10) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 8). White and black boxes depict diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test are shown. (C and D) Systolic blood pressure (C) and diastolic blood pressure (D) alteration in response to hypoxia in TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 5) compared to HIF-2&#x03B1;<sup>WT</sup> (black, n = 5) measured by radiotelemetry. Shift and duration of 10&#x0025; O<sub>2</sub> are indicated in the graph. White and black boxes depict diurnal and nocturnal periods, respectively. Data are presented as averaged blood pressure values every hour &#x00B1;SEM. Recovery across the hypoxia period was analysed by one-phase association curve fitting. (E) Physical activity recorded by radiotelemetry of HIF-2&#x03B1;<sup>WT</sup> (black, n = 5) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 5) littermates exposed to 10&#x0025; O<sub>2</sub> environment. Shift and duration of 10&#x0025; O<sub>2</sub> are indicated in the graph. White and black boxes depict diurnal and nocturnal periods, respectively. Data are presented as averaged blood pressure values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test is shown. (F-Q) Circadian fluctuations in systolic blood pressure, diastolic blood pressure, subcutaneous temperature and physical activity of HIF-2&#x03B1;<sup>WT</sup> (black, n = 5) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 5) after 7 days (F-I), 14 days (J-M) and 21 days (N-Q) of Ang II infusion recorded by radiotelemetry. White and black boxes represent diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test are shown. ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_figS5a.tif"/>
</fig>
<fig id="figS6a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6-figure supplement 1. Related to <xref rid="fig6" ref-type="fig">Figure 6</xref>.</label>
<caption>
<p>Whole-body metabolic activity of TH-HIF-2&#x03B1;<sup>KO</sup> in response to fasting-induced hypoglycemia. (A-D) Oxygen consumption (A, VO<sub>2</sub>), carbon dioxide generation (B, VCO<sub>2</sub>), respiratory exchange rate (C) and heat production (D) of HIF-2&#x03B1;<sup>WT</sup> (black, n = 7) and TH-HIF-2&#x03B1;<sup>KO</sup> (red, n = 7) littermates under feed and over night fasting conditions. White and black boxes represent diurnal and nocturnal periods, respectively. Data are presented as averaged values every hour &#x00B1;SEM. Area under the curve followed by unpaired t-test are shown. ns, non-significant.</p></caption>
<graphic xlink:href="250928_figS6a.tif"/>
</fig>
<fig id="figS7a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7-figure supplement 1.</label>
<caption>
<p>mTORC1 activity in SCG TH<sup>&#x002B;</sup>sympathetic neurons and effect of rapamycin treatment. (A) Double TH and p-S6 (mTORC1 activation marker) immunofluorescence on adult wild type SCG slices after 14 days in hypoxia (10&#x0025; O<sub>2</sub>). TH<sup>&#x002B;</sup> outlined area indicates the region used for pixels quantification. Scale bars: 100 &#x00B5;m. SCG, superior cervical ganglion. (B) Quantification of p-S6 (red) and TH (green) mean pixels intensity within the SCG TH<sup>&#x002B;</sup> area of wild type mice breathing 21&#x0025; O<sub>2</sub> or 10&#x0025; O<sub>2</sub> for 14 days. Each data point depicts the average of 3-4 pictures. 21&#x0025; O<sub>2</sub>, n = 3; 10&#x0025; O<sub>2</sub>, n = 4. Data are presented as mean &#x00B1;SEM. Unpaired t-test, ns, non-significant. (C) Representative micrographs of TH and p-S6 double immunostaining of HIF-2&#x03B1;<sup>WT</sup> and TH-HIF-2&#x03B1;<sup>KO</sup> embryonic (E18.5) carotid bifurcations. SCG TH<sup>&#x002B;</sup> outlined area indicates the region used for pixels quantification. SCG, superior cervical ganglion. Scale bars: 100 &#x00B5;m. (D) Quantitative analysis performed on HIF-2&#x03B1;<sup>WT</sup> (black) and TH-HIF-2&#x03B1;<sup>KO</sup> (red) micrographs previously immune-stained for TH (green) and p-S6 (red). Each data point depicts the average of 3-4 pictures. 21&#x0025; O<sub>2</sub>, n = 12; 10&#x0025; O<sub>2</sub>, n = 10. Data are presented as mean &#x00B1;SEM. Unpaired t-test, ns, non-significant. (E) Double TH and p-S6 immunofluorescence on vehicle control or rapamycin injected adult wild type SCG slices after 14 days breathing in a 10&#x0025; O<sub>2</sub> atmosphere. Notice the absence of p-S6 signal as a consequence of mTORC inhibition by rapamycin. SCG, superior cervical ganglion. CB, carotid body. Scale bars: 100 &#x00B5;m. (F) Haematocrit levels of vehicle control (n = 14) andrapamycin (n = 14) injected mice after 7 days at 10&#x0025; O<sub>2</sub>. Un-paired t-test, ns, non-significant.</p>
</caption>
<graphic xlink:href="250928_figS7a.tif"/>
</fig>
</sec>
</back>
</article>